Patent Grant
10988738
The present invention relates to a novel soluble coenzyme-binding glucose dehydrogenase, a method for producing the coenzyme-binding glucose dehydrogenase, and a microorganism having an ability of producing the coenzyme-binding glucose dehydrogenase.
The invention also relates to a method for measuring glucose in a sample employing the coenzyme-binding glucose dehydrogenase, and a reagent and a reagent composition containing the coenzyme-binding glucose dehydrogenase. Moreover, the invention relates to utilization in producing and analyzing a material such as a starting material, including a method for producing an organic compound.
The invention further relates to a biosensor capable of rapidly and conveniently quantifying a particular component in a sample at a high accuracy. Practically, the invention relates to a glucose sensor employing the coenzyme-binding glucose dehydrogenase.
Glucose is present in blood and utilized as an important marker for diabetes. A method for measuring a glucose has conventionally been a chemical method or an enzymatic method, and an enzymatic method is regarded generally to be excellent in view of the specificity and the safety. Such an enzymatic method is, for example, be a measurement using a glucose oxidase, glucose-6-phosphate dehydrogenase or an NAD(P)-dependent glucose dehydrogenase. However, the methods employing the glucose oxidase and the glucose-6-phosphate dehydrogenase are not convenient reaction systems since they employ a plural of enzymes. The methods employing the glucose-6-phosphate dehydrogenase and the NAD(P)-dependent glucose dehydrogenase pose a complication due to the requirement of adding a coenzyme NAD(P) to the reaction systems.
Recently, various biosensors were proposed as modes for quantifying a particular component in a sample conveniently without diluting or stirring a sample solution. For example, a biosensor was proposed in which an electrode system consisting of an action electrode, a counter electrode and a reference electrode was formed by a screen printing on an insulating board. This electrode system and the like was in contact with an enzymatic reaction layer formed thereon containing a hydrophilic polymer, a redox enzyme and an electron acceptor.
The number of diabetes patient is increasing year by year, and a method for measuring a blood sugar and a means for controlling the blood sugar level are desired which can be utilized not only in a hospital but also at home and which is convenient. While a simple glucose sensor is employed currently for measuring the blood sugar, it frequently employs a glucose oxidase which is highly suspected to give a measured value involving an error due to a level of the residual oxygen. On the other hand, a biosensor employing a glucose dehydrogenase which is dependent on a nicotinamide-based coenzyme exhibits a high background noise and involves a complicated reaction system due to the requirement of adding a coenzyme or an auxiliary enzyme separately, and it also suffers from a disadvantage due to the requirement of an expensive optical system upon measuring a chromogenic system.
As an enzyme which is not affected by the residual oxygen level and which can act on glucose in the absence of NAD(P), a glucose dehydrogenase whose coenzyme is pyrroloquinolinequinone is known, but the pyrroloquinolinequinone problematically tends to dissociate from the enzyme. A glucose dehydrogenase whose coenzyme is pyrroloquinolinequinone disclosed in JP-A-2000-350588 and JP-A-2001-197888 has a disadvantageously low selectivity for glucose. On the other hand, a glucose dehydrogenase whose coenzyme is the pyrroloquinolinequinone derived from Escherichia coli (JP-A-10-243786), a glucose dehydrogenase whose coenzyme is the pyrroloquinolinequinone derived from Pseudomonas sp. (Agric. Biol. Chem. (1980) 44:1505-1512) and a glucose dehydrogenase whose coenzyme is the pyrroloquinolinequinone derived from Gluconobacter suboxydans (Agric. Biol. Chem. (1981) 45:851-861) had the respective activity on maltose of 3%, 3.2% and 5%, but were accompanied with the complication due to the requirement of a solubilization and an extraction of the enzymes since they were existing in a membrane fraction of the bacterial bodies.
The coenzyme-binding glucose dehydrogenases which oxidize a hydroxyl group in the 3rd-position of glucose were also reported in J. Biol. Chem. (1967) 242: 3665-3672, Appl. Microbiol. Biotechnol. (1999) 51: 58-64, Appl. Biochem. Biotechnol. (1996) 56: 301-310 and Enzyme Microb. Technol. (1998) 22:269-274, but any of them exhibits a poor selectivity for glucose. Since maltose is employed widely as an infusion component and the blood maltose level in an infused patient is high, it is desired to develop an enzyme for measuring the blood sugar which is capable of acting specifically on glucose and has low activity especially on maltose.
In order to respond the industrial needs mentioned above, an objective of the invention is to provide a novel glucose dehydrogenase which exhibits an excellent substrate-recognizing ability toward glucose and which has low activity on maltose, and also to provide a method for producing the same and a microorganism having an ability of producing the same.
Another objective of the invention is to provide excellent glucose measuring method, measuring reagent and biosensor which employ the novel glucose dehydrogenase and which are capable of quantifying glucose rapidly and conveniently at a high accuracy, as well as a glucose-eliminating reagent.
The invention is accomplished for solving the problems mentioned above, and the inventors made an effort in various ways and then focused on a novel soluble coenzyme-binding glucose dehydrogenase. The coenzyme-binding glucose dehydrogenase catalyzes a glucose-oxidizing reaction in the presence of an electron acceptor, and is classified for example as EC (Enzyme Code) 1.1.99. The inventors also made an effort in characterizing various microorganisms producing the coenzyme-binding glucose dehydrogenase, and finally discovered a coenzyme-binding glucose dehydrogenase-producing microorganism and a coenzyme-binding glucose dehydrogenase.
The invention provides a glucose dehydrogenase to which a coenzyme is bound continuously upon a catalytic reaction. The coenzyme-binding glucose dehydrogenase has a physicochemical ability of catalyzing a reaction for oxidizing glucose, especially a hydroxyl group in the 1st-position of glucose, in the presence of an electron acceptor. The coenzyme-binding glucose dehydrogenase has 5% or less activity to maltose, preferably 3% or less; thus it has a poor activity on the maltose. On the other hand, the coenzyme-binding glucose dehydrogenase allows its enzymatic activity to be inhibited characteristically by 50% or more at 5 mM of 1,10-phenanthroline, preferably by 50% or more at 2 mM as a final concentration of 1,10-phenanthroline, more preferably by 50% or more at 1 mM of 1,10-phenanthroline. The coenzyme-binding glucose dehydrogenase preserves its residual enzymatic activity at a level as high as 85% or more even after a heat treatment for 15 minutes at 50° C. in the presence of 50 mM sodium citrate buffer solution (pH5.5). The coenzyme which is bound to the inventive glucose dehydrogenase may for example be a flavin compound, including a coenzyme such as flavin adenine dinucleotide. The invention also includes, with respect to a protein having the characteristics of those of the coenzyme-binding glucose dehydrogenase and/or characteristics equivalent substantially thereto as well as its salt, a protein which has an amino acid sequence encoding the protein or an amino acid sequence containing a mutation resulting from a deletion, substitution or addition of one or more amino acid residues in the sequence and which is biologically active and stable. Moreover, the inventive coenzyme-binding glucose dehydrogenase is a microorganism-derived coenzyme-binding glucose dehydrogenase, preferably a eukaryotic microorganism-derived coenzyme-binding glucose dehydrogenase, more preferably the deposited strain FERM BP-08578-derived coenzyme-binding glucose dehydrogenase.
It has already been observed that a glucose dehydrogenase whose coenzyme is a flavin adenine dinucleotide exists in a cytoplasm fraction and a culture of Aspergillus oryzae (TCHAN-GI BAK (BIOCHEMICA ET BIOPHYSICA ACTA. (1967) 139:277-293)). However, this glucose dehydrogenase is inhibited only by a heavy metal ion, and characterized physicochemically in that it is not inhibited by a metal chelator including 1,10-phenanthroline. Accordingly, in a measurement system employing this glucose dehydrogenase, only a heavy metal can be used as a quencher, which poses a problem associated with a complicated heavy metal waste disposal after completion of the reaction. In addition, this enzyme has a poor stability, and is problematic when used practically. On the other hand, the coenzyme-binding glucose dehydrogenase discovered in this invention is characterized by its higher stability when compared with that of the known Aspergillus oryzae-derived coenzyme-binding glucose dehydrogenase, and also by a favorably convenient handling for quenching because of its ability of being inhibited by a trace amount of 1,10-phenanthroline in addition to a heavy metal ion.
The invention provides a method for producing the novel soluble coenzyme-binding glucose dehydrogenase.
The invention provides a microorganism having an ability of producing the novel soluble coenzyme-binding glucose dehydrogenase. The microorganism is preferably a eukaryotic microorganism, more preferably, genus Aspergillus, further preferably, Aspergillus terreus, and most preferably, the deposited strain FERM BP-08578.
The invention provides a method using the novel soluble coenzyme-binding glucose dehydrogenase. Preferably, a method for measuring glucose using the coenzyme-binding glucose dehydrogenase is provided for measuring glucose in a sample. A method for eliminating glucose using the coenzyme-binding glucose dehydrogenase and a method for producing an organic compound are also provided.
The invention provides a reagent containing the novel soluble coenzyme-binding glucose dehydrogenase. The reagent is preferably a glucose-measuring reagent containing the coenzyme-binding glucose dehydrogenase employed for measuring the glucose in a sample, and a glucose-eliminating reagent containing the coenzyme-binding glucose dehydrogenase as well as an organic compound-producing reagent.
The invention provides a reagent composition containing the novel soluble coenzyme-binding glucose dehydrogenase. The composition is preferably a glucose-measuring composition containing the coenzyme-binding glucose dehydrogenase employed for measuring glucose in a sample, and a glucose-eliminating composition containing the coenzyme-binding glucose dehydrogenase as well as an organic compound-producing composition.
The invention provides a biosensor employing the novel soluble coenzyme-binding glucose dehydrogenase and a biosensor capable of quantifying and/or qualifying a particular component in a sample. Such a biosensor is preferably a glucose sensor employing the coenzyme-binding glucose dehydrogenase.
One preferred embodiment of these inventive measurement methods, measurement reagents, measurement compounds and biosensors is characterized by the use of potassium ferricyanide (potassium hexacyanoferrate (III)) at a final concentration of 2 mM to 500 mM.
In the invention, a value of percentage (%) represents “substrate specificity”. For example, in the expressions “activity to maltose”, “activity” toward maltose” or an analogous expression, according to the coenzyme-binding glucose dehydrogenase, such a value also represents for a percentage of a relative intensity of an enzymatic activity on the maltose or other action targets based on the enzymatic activity on glucose being regarded as 100%.
An inventive coenzyme-binding glucose dehydrogenase may for example be an enzyme classified as EC 1.1.99, preferably EC 1.1.99.10, EC 1.1.99.13 or EC 1.1.99.17, and is a coenzyme-binding enzyme, preferably a soluble coenzyme-binding enzyme. That is, it is an enzyme capable of being obtained in the state of an aqueous solution without using any surfactant in a step of extraction/purification of the enzyme. As used herein, a coenzyme may be any flavin compound, such as flavin adenine dinucleotide, flavin mononucleotide and the like.
The inventive coenzyme-binding glucose dehydrogenase may be a glucose dehydrogenase to which a coenzyme is bound always over the period of the catalytic reaction. The coenzyme-binding glucose dehydrogenase has at least the following characteristics; that is a physicochemical property for catalyzing a reaction for oxidizing glucose in the presence of an electron acceptor, especially for catalyzing a reaction for oxidizing a hydroxyl group in the 1st-position of the glucose. In addition, the coenzyme-binding glucose dehydrogenase has a low activity on maltose, which is at a level for example of 5% or below, preferably 3% or below. Moreover, the enzymatic activity of the coenzyme-binding glucose dehydrogenase is inhibited by 50% or more at 5 mM of 1,10-phenanthroline, preferably by 50% or more at 2 mM as a final concentration of 1,10-phenanthroline, more preferably by 50% or more at 1 mM of 1,10-phenanthroline, especially by 60% or more at 1 mM of 1,10-phenanthroline. The coenzyme-binding glucose dehydrogenase preserves its residual enzymatic activity at a level as high as 85% or more even after a heat treatment for 15 minutes at 50° C. in the presence of 50 mM sodium citrate buffer solution (pH5.5). Moreover, the invention relates to coenzyme-binding glucose dehydrogenase having the physicochemical characteristics described above; or an amino acid sequence encoding the physicochemical characteristics, wherein the amino acid sequence is a protein or a salt as follows: the amino acid sequence encoding the protein or the salt contains a mutation resulting from a deletion, substitution or addition of one or more amino acid residues in the sequence, and such the resultant protein and the salt are biologically active and stable, with respect to the protein or its salt having the activity substantially equivalent to that of the coenzyme-binding glucose dehydrogenase.
The protein or its salt, which are the inventive coenzyme-binding glucose dehydrogenase, is preferably one derived from a microorganism having the physicochemical characteristics described above. A microorganism from which the inventive coenzyme-binding glucose dehydrogenase is derived and a microorganism having an ability of producing the inventive coenzyme-binding glucose dehydrogenase may for example be those classified into prokaryotic microorganisms such as genus Archangium, genus Arcaeoglobus, genus Arsenophonus, genus Ahrensia, genus Aureobacterium, genus Aerococcus, genus Aeropyrum, genus Aeromicrobium, genus Aeromonas, genus Aquifex, genus Aquaspirillum, genus Aquabacter, genus Aquabacterium, genus Aquamicrobium, genus Actinolloteichus, genus Actinokineospora, genus Actinocorallia, genus Actinosynnema, genus Actinosporangium, genus Actinobaculum, genus Actinobacilus, genus Actinopycnidium, genus Actinobispora, genus Actinoplanes, genus Actinopolyspora, genus Actinopolymorpha, genus Actinomyces, genus Actinomadura, genus Acrocarpospora, genus Agrococcus, genus Agrobacterium, genus Agromyces, genus Agromatium, genus Agromonas, genus Achromobacter, genus Acholeplasma, genus Asaia, genus Acidianus, genus Acidispaera, genus Acidiphilium, genus Acidimicrobium, genus Acidilobus, genus Acidaminococcus, genus Acidaminobacter, genus Acidithiobacillus, genus Agitococcus, genus Acidothermus, genus Acidocella, genus Acidobacterium, genus Acidovorax, genus Acidomonas, genus Acinetobacter, genus Asiticcacaulis, genus Asteroleplasma, genus Acetitomaculum, genus Acetivibrio, genus Acetoanaerobium, genus Acetogenium, genus Acetothermus, genus Acetonema, genus Acetobacter, genus Acetobacterium, genus Acetohalobium, genus Acetofilamentum, genus Acetomicrobium, genus Azoarcus, genus Azospira, genus Azospirillum, genus Azotobacter, genus Azonexus, genus Azovibrio, genus Azomonas, genus Azomonotrichon, genus Azorhizobium, genus Azorhizophilus, genus Atopobacter, genus Atopobium, genus Anaplasma, genus Aneurinibacillus, genus Anaeroarcus, genus Anaerococcus, genus Anaerosinus, genus Anaerobacter, genus Anaerobaculum, genus Anaerobispirillum, genus Anaerovibrio, genus Anaerofilum, genus Anaeroplasma, genus Anaerobranca, genus Anaerovorax, genus Anaeromusa, genus Anaerorhabdus, genus Anoxybacillus, genus Abiotrophia, genus Afipia, genus Amaricoccus, genus Amycolata, genus Amycolatopsis, genus Aminobacter, genus Aminobacterium, genus Aminomonas, genus Amoebobacter, genus Ammoniphilus, genus Ammonifex, genus Amorphosporangium, genus Arachnia, genus Alysiella, genus Alicyclobacillus, genus Alishewanella, genus Alcanivorax, genus Arcanobacterium, genus Alcaligenes, genus Alkalibacterium, genus Alkaliphilus, genus Arcobacter, genus Arthrobacter, genus Alterococcus, genus Alteromonas, genus Albibacter, genus Alloiococcus, genus Allochromatium, genus Arhodomonas, genus Allomonas, genus Allorhizobium, genus Anacalochloris, genus Anacalomicrobium, genus Angiococcus, genus Angulomicrobium, genus Ancylobacter, genus Antarctobacter, genus Amphibacillus, genus Ampullariella, genus Ignavigranum, genus Idiomarina, genus Isochromatium, genus Isosphaera, genus Ideonella, genus Ilyobacter, genus Intrasporagium, genus Weeksella, genus Wigglesworthia, genus Williamsia, genus Wolinella, genus wolbachia, genus Ureplasma, genus Ureibacillus, Eikenella, genus Ehrlichia, genus Exiguobacterium, genus Excellospora, genus Ectothiorhodospira, genus Aegyptianella, genus Eggerthella, genus Escherichia, genus Edwardsiella, genus Ewingella, genus Eperythrozonn, genus Erysipelothrix, genus Erythrobacter, genus Erythromicrobium, genus Erythromonas, genus Elytrosporangium, genus Yersinia, genus Erwinia, genus Eremococcus, genus Ensifer, genus Enterococcus, genus Enterobacter, genus Entomoplasma, genus Enhydrobacter, genus Empedobacter, Oenococcus, genus Oerskovia, genus Oceanimonas, genus Oceanospirillum, genus Oxalobacater, genus Oxalophagus, genus Oxobacter, genus Octadecabacter, genus Ochrobactrum, genus Oscillochloris, genus Oscillospira, genus Obesumbacterium, genus Orientia, genus Oligella, genus Oligotropha, genus Oribaculum, genus Ornithinicoccus, genus Ornithinimicrobium, genus Ornithobacterium, genus Orenia, genus Gardnerella, genus Carnimonas, genus Carnobacterium, genus Couchioplanes, genus Cowdria, genus Caulobacter, genus Caseobacter, genus Catenibacterium, genus Catenuloplanes, genus Catenococcus, genus Catellatospora, genus Catonella, genus Capsularis, genus Capnocytophaga, genus Gallionella, genus Carvophanon, genus Gallicola, genus Calymmatobacterium, genus Cardiobacterium, genus Caldicellulosiruptor, genus Caldivirga, genus Calderobacterium, genus Carboxydibrachium, genus Carboxydothermus, genus Carbophilus, genus Caloramator, genus Xanthobacter, Xanthomonas, genus Xylella, genus Xylophilus, genus Xenorhabdus, genus Kitasatoa, genus Kirasatospora, genus Chitinophaga, genus Kytococcus, genus Kineococcus, genus Kineosporia, genus Quinella, genus Kibdelosporangium, genus Campylobacter, genus Kingella, genus Kutzneria, genus Cupriavidus, genus Craurococcus, genus Glaciecola, genus Gracilibacillus, genus Granulicatella, genus Grahamella, genus Clavibacter, genus Chlamydia, genus Chlamydophila, genus Cryobacterium, genus Glycomyces, genus Chrysiogenes, genus Cristispira, genus Chryseobacterium, genus Chryseomonas, genus Crinalium, genus Cryptosporangium, genus Cryprobacterium, genus Kluyvera, genus Kribbella, genus Gluconacetobacter, genus Gluconobacter, genus Kurthia, genus Curtobacterium, genus Crenothrix, genus Klebsiella, genus Clevelandina, genus Crossiella, genus Clostridium, genus Clobicatella, genus CHromatium, genus Chromobacterium, genus Chromohalobacter, genus Chloronema, genus Chrorobium, genus Chloroflexus, genus Chloroherpeton, genus Caedibacter, genus Ketogulonicigenium, genus Gemmata, genus Gemmiger, genus Gemella, genus Gemmobacter, genus Chelatococcus, genus Chelatobacter, genus Gelidibacter, genus Coenonia, genus Coxiella, genus Kocuria, genus Koserella, genus Coprococcus, genus Coprothermobacter, genus Coprobacillus, genus Comamonas, genus Coriobacterium, genus Corynebacterium, genus Collinsella, genus Colwellia, genus Gordonia, genus Conglomeromonas, genus Chondromyces, genus Thermaerobacter, genus Thermus, genus Thermacetogenium, genus Thermanaerovibrio, genus Thermicanus, genus Thermithiobacillus, genus Thermoactinomyces, genus Thermoanaerobacter, genus Thermoanaerobacterium, genus Thermoanaerobium, genus Thermocladium, genus Thermocrispum, genus Thermocrinis, genus Thermochromatium, genus Thermococcus, genus Thermosipho, genus Thermosyntropha, genus Thermosphaera, genus Thermothrix, genus Thermodesulfobacterium, genus Thermodesulfovibrio, genus Thermodesulforhabdus, genus Thermoterrabacterium, genus Thermotoga, genus Thermonema, genus Thermohydrogenium, genus Thermobacteroides, genus Thermobacillus, genus Thermohalobacter, genus Thermobispora, genus Thermobifida, genus Thermofilum, genus Thermobranchium, genus Thermoplasma, genus Thermoproteus, genus Thermomicrobium, genus Thermomonospora, genus Thermoleophilum, genus Cytophaga, genus Zymobacter, genus Zymophilus, genus Zymomonas, genus Sagittula, genus Saccharococcus, genus Saccharothrix, genus Saccharobacter, genus Saccharopolyspora, genus Saccharomonospora, genus Zavarzinia, genus Subtercola, genus Saprospira, genus Samsonia, genus Salinicoccus, genus Salinivibrio, genus Salibacillus, genus Sarcobium, genus Sarcina, genus Salmonella, genus Salegentibacter, genus Sanguibacter, genus Sandaracinobater, genus Dyadobacter, genus Dialister, genus Dietzia, genus Shewanella, genus Geothrix, genus Geodermatophilus, genus Geotoga, genus Geobacter, genus Geobacillus, genus Geovibrio, genus Dictyoglomus, genus Cycloclasticus, genus Psychroserpens, genus Psychrobacter, genus Cyclobacterium, genus Psychroflexus, genus Psychromonas, genus Sigella, genus Dichelobacter, genus Dichoromicrobium, genus Dysgonomonas, genus Cystobacter, genus Citrobacter, genus Synergistes, genus Sinorhizobium, genus Diplocalyx, genus Simkania, genus Simonsiella, genus Janibacter, genus Janthinobacterium, genus Pseudaminobacter, genus Pseudoamyclata, genus Pseudoalteromonas, genus Pseudoxanthomonas, genus Pseudocaedibacter, genus Pseudonocardia, genus Pseudobutyrivibrio, genus Pseudomonas, genus Pseudoramibacter, genus Schwartzia, genus Jonesia, genus Johnsonella, genus Silicibacter, genus Syntrophus, genus Syntrophococcus, genus Syntrophothermus, genus Syntrophospora, genus Syntrophobacter, genus Syntrophobotulus, genus Syntrophomonas, genus Symbiotes, genus Symbiobacterium, genus Zoogloea, genus Duganella, genus Schineria, genus Succiniclasticum, genus Succinispira, genus Succinivibrio, genus Succinimonas, genus Skermania, genus Skermanella, genus Starkeya, genus Stappia, genus Staphylococcus, genus Staphylothermus, genus Staleya, genus Stygiolobus, genus Stibiobacter, genus Stigmatella, genus Stetteria, genus Stenotrophomonas, genus Stella, genus Suttrella, genus Suttonella, genus Stomatococcus, genus Streptoalloteichus, genus Streptococcus, genus Streptosporangium, genus Streptoverticillium, genus Streptobacillus, genus Streptomyces, genus Streptomonospora, genus Spirillum, genus Spirilliplanes, genus Spirillospora, genus Spirosoma, genus Spiroplasma, genus Spirochaeta, genus Sphingobacterium, genus Sphingobium, genus Sphingopyxis, genus Sphaerotilus, genus Spaerobacter, genus Sphingomonas, genus Sporichthya, genus Sporocytophaga, genus Sporosarcina, genus Sporotomaculum, genus Sporobacter, genus Sporobacterium, genus Sporohalobacter, genus Sporomusa, genus Sporolactobacillus, genus Smithella, genus Slackia, genus Sulfitobacter, genus Sulfobacillus, genus Sulfophobococcus, genus Sulfolobus, genus Sulfurisphaera, genus Sulfurococcus, genus Sulforospirillum, genus Cedecea, genus Setobacterium, genus Sebaldella, genus Serratia, genus Seliberia, genus Cellvibrio, genus Cerpula, genus Serpulina, genus Serpens, genus Cellulosimicrobium, genus Cellulophaga, genus Cellulomonas, genus Selenihalanaerobacter, genus Selenomonas, genus Centipeda, genus Sodalis, genus Zobellia, genus Solobacterium, genus Thauera, genus Dactylosporangium, genus Tatumella, genus Tatlockia, genus Thalassomonas, genus Thialkalicoccus, genus Thialkalivibrio, genus Thialkalimicrobium, genus Thiocapsa, genus Thiococcus, genus Thiodictyon, genus Thiocystis, genus Thiospira, genus Thiospirillum, genus Thiosphaera, genus Thiothrix, genus Thiobacterium, genus THiobacillus, genus Thiohalocapsa, genus Thioflavicoccus, genus Thiovulum, genus THioploca, genus THiopedia, genus Thiomargarita, genus Thiomicrospira, genus Thiomonas, genus Thiolamprovum, genus Thiorhodococcus, genus THiorhodospira, genus Thiorhodovibrio, genus Tissierella, genus Chania, genus Tindallia, genus Tsukamurella, genus Turicella, genus Deinococcus, genus Deinobacter, genus Taylorella, genus Tectibacter, genus Dechlorosoma, genus Dechloromonas, genus Tessaracoccus, genus Desulfacinum, genus Desulfitobacterium, genus Desulfocapsa, genus Desulfococcus, genus Desulfosarcina, genus Desulfospira, genus Desulfosporosinus, genus Desulfocella, genus Desulfotalea, genus Desulfotignum, genus Desulfotomaculum, genus Desulfonatronum, genus Desulfonatronovibrio, genus Desulfonispora, genus Desulfonema, genus Desulfovirga, genus Desufobacter, genus Desulfobacterium, genus Desulfobacula, genus Desulfobacca, genus Desulfobulbus, genus Desulfohalobium, genus Desulfovibrio, genus Desulfofustis, genus Desulfofaba, genus Desulfofrigus, genus Desulfomicrobium, genus Desulfomonas, genus Desulfomonile, genus Desulforhabdus, genus Desulforhopalus, genus Desulfurella, genus Desulfurococcus, genus Desulfurobacterium, genus Desulfuromusa, genus Desulfuromonas, genus Desulfurolobus, genus Desemzia, genus Dethiosulfovibrio, genus Tetragenococcus, genus Tetrasphaera, genus Denitrobacterium, genus Denitrovibrio, genus Dehalobacter, genus Tepidimonas, genus Deferribacter, genus Defluvibacter, genus Devosia, genus Demetria, genus Terracoccus, genus Terrabacter, genus Derxia, genus Delftia, genus Dermacoccus, genus Dermatophilus, genus Dermabacter, genus Telluria, genus Deleya, genus Dendrosporobacter, genus Toxothrix, genus Trabulsiella, genus Trichlorobacter, genus trichococcus, genus Tlumonas, genus Treponema, genus Dolosigranulum, genus Dolosicoccus, genus Tropheryma, genus Neisseria, genus Natrialba, genus Natrinema, genus Natroniella, genus Natronincola, genus Natronococcus, genus Natronobacterium, genus Natronomonas, genus NAtronorubrum, genus Nannocystis, genus Nitrococcus, genus Nitrospina, genus Nitrospira, genus Nitrosococcus, genus Nitrosospira, genus Nitrosomonas, genus Nitorosolobus, genus Nitrobacter, genus Neochlamydia, genus Neorickettsia, genus Nesterenkonia, genus Nevskia, genus Neptunomonas, genus Nocardia, genus Nocardioides, genus Nocardiopsis, genus Nonomuraea, genus Novosphingobium, genus Virgibacillus, genus Hydrogenobacter, genus Hydrogenovibrio, genus Hydrogenophaga, genus Hydrogenophilus, genus Hyperthermus, genus Hyphomicrobium, genus Hyphomonas, genus Paucimonas, genus Bacterionema, genus Bacteriovorax, genus Bacteroides, genus Bactoderma, genus Vagococcus, genus Pasteuria, genus Pasteurella, genus Bacillus, genus Papillibacter, genus Hafnia, genus Hahella, genus Paracraurococcus, genus Parachlamydia, genus Paracoccus, genus Halanaerobacter, genus Halanaerobium, genus Paralactobacillus, genus Variovorax, genus Haliscomenobacter, genus Bartonella, genus Balneatrix, genus Palaeococcus, genus Hallella, genus Haloarcula, genus Haloincola, genus Halochromatium, genus Halococcus, genus Halothermothrix, genus Halogeometricum, genus Halospirulina, genus Halocella, genus Halothiobacillus, genus Haloterrigena, genus Halonatronum, genus Halobaculum, genus Halobacterium, genus Halobacteroides, genus Halobacillus, genus Halobvibrio, genus Haloferax, genus Halomethanococcus, genus Halomonas, genus Halorhabdus, genus Halorubrum, genus Halorubrobacterium, genus Halorhodospira, genus Pantoea, genus Pandoraea, genus Vampirovibrio, genus Picrophilus, genus Piscirickettsia, genus Hippea, genus Vitreoscilla, genus Bifidobacterium, genus Vibrio, genus Hymenobacter, genus Pimelobacter, genus Pilimelia, genus Hirschia, genus Pirella, genus Pirellula, genus Pyrococcus, genus Pyrodictium, genus Pillotina, genus Pyrobaculum, genus Bilophila, genus Pyrolobus, genus Faenia, genus Facklamia, genus Phascolarctobacterium, genus Falcivibrio, genus Fundibacter, genus Finegoldia, genus Fibrobacter, genus Filibacter, genus Filifactor, genus Phyllobacterium, genus Filobacillus, genus Filomicrobium, genus Phaeospirillum, genus Phenylobacterium, genus Ferriacterium, genus Ferrimonas, genus Fervidobacterium, genus Ferroglobus, genus Ferroplasma, genus Phocoenobacter, genus Photobactrium, genus Photorhabdus, genus Formivibrio, genus Fusobacterium, genus Buttiauxella, genus Butyrivibrio, genus Bdellovibrio, genus Budvicia, genus Phennigia, genus Buchnera, genus Fusibacter, genus Prauserella, genus Pragia, genus Bracyspira, genus Bracybacterium, genus Bracymonas, genus Blastochloris, genus Blastococcus, genus Blastobacter, genus Blastomonas, genus Blattabacterium, genus Bradyrhizobium, genus Frateuria, genus Branhamella, genus Planococcus, genus Planotetraspora, genus Planobispora, genus Planopolyspora, genus Planomicrobium, genus Planomonospora, genus Flavimonas, genus Flavobacterium, genus Flammeovirga, genus Frankia, genus Planctomyces, genus Francisella, genus Friedmanniella, genus Frigoribacterium, genus Fluoribacter, genus Burkholderia, genus Brucella, genus Bulleidia, genus Flexistipes, genus Flexithrix, genus Flexibacter, genus Flectobacillus, genus Plesiomonas, genus Brenneria, genus Brevundimonas, genus Brevinema, genus Brevibacterium, genus Brevibacillus, genus Prevotella, genus Prochlorococcus, genus Prochlorothrix, genus Prochloron, genus Brochothrix, genus Prosthecochloris, genus Prosthecobacter, genus Prosthecomicrobium, genus Proteus, genus Protomonas, genus Propionigenium, genus Propionispira, genus Propionispora, genus Propionibacter, genus Propionibacterium, genus Propionivibrio, genus Propioniferax, genus Providencia, genus Promicromonospora, genus Prolinoborus, genus Beijejrinckia, genus Veillonella, genus Beutenbergia, genus Beggiatoa, genus Pectinatus, genus Pectobacterium, genus Pediococcus, genus Pedobacter, genus Pedomicrobium, genus Petrotoga, genus Paenibacillus, genus Beneckea, genus Peptococcus, genus Peptostreptococcus, genus Peptoniphilus, genus Haemobartonella, genus Haemophilus, genus Heliothrix, genus HEliobacterium, genus Heliobacillus, genus HEliophilum, genus Heliorestis, genus Helicobacter, genus Pelistega, genus Pelczaria, genus Bergeyella, genus Helcococcus, genus Verrucosispora, genus Verrucomicrobium, genus Persicobacter, genus Herbaspirillum, genus Herbidospora, genus Herpetosiphon, genus Pelodictyon, genus Pelospora, genus Pelobacter, genus Vogesella, genus Bogoriella, genus Bosea, genus Polaribacter, genus Polaromonas, genus Hollandina, genus Polyangium, genus Polynucleobacter, genus Volcaniella, genus Bordetella, genus Holdemania, genus Porphyrobacter, genus Porphyromonas, genus Borrelia, genus Holospora, genus Holophaga, genus Hongia, genus Meiothermus, genus Mycobacterium, genus Mycoplasma, genus Mycoplana, genus Mycetocola, genus Myroides, genus Magnetospirillum, genus Macrococcus, genus Macromonas, genus Massilia, genus Maricaulis, genus Marichromatium, genus Marinococcus, genus Marinitoga, genus Marinilabilia, genus Marinospirillum, genus Marinobacter, genus Marinobacterium, genus Marinomonas, genus Marmoricola, genus Malonomonas, genus Mannheimia, genus Micavibrio, genus Myxococcus, genus Microellobosporia, genus Micrococcus, genus Microcyclus, genus Microcystis, genus Microscilla, genus Microsphaera, genus Microtetraspora, genus Microvirgula, genus Microbacterium, genus Microbulbifer, genus Microbispora, genus Micropruina, genus Micropolyspora, genus Micromonas, genus Micromonospora, genus Microlunatus, genus Mitsuokella, genus Megasphaera, genus Megamonas, genus Mesophilobacter, genus Mesoplasma, genus Mesorhizobium, genus Methanimicrococcus, genus Methanocalculus, genus Methanoculleus, genus Methanogenium, genus Methanocorpusculum, genus Methanococcoides, genus Methanococcus, genus Methanothermus, genus Methanothermobacter, genus Methanosaeta, genus Methanosarcina, genus Methanospirillum, genus Methanosphaera, genus Methanothrix, genus Methanobacterium, genus Methanohalobium, genus Methanohalophilus, genus Methanopyrus, genus Methanofollis, genus Methanoplanus, genus Methanoburevibacter, genus Methanomicrobium, genus Methanolacinia, genus Methanolobus, genus Methallosphaera, genus Methylarcula, genus Methylocaldum, genus Methylococcus, genus Methylcarcina, genus Methylocystis, genus Methylosinus, genus Methysphaera, genus Methylcella, genus Methylbacter, genus Methylbacterium, genus Methylobacillus, genus Methylopila, genus Methylophaga, genus Methylpholus, genus Methylovorus, genus Methylmicrobium, genus Methylomonas, genus Methylorhabdus, genus Meniscus, genus Melittangium, genus Melissococcus, genus Moellerella, genus Moorella, genus Mogibacterium, genus Modestobacter, genus Mobiluncus, genus Moraxella, genus Morganella, genus Mortiella, genus Morococcus, genus Eubacterium, genus lodobacter, genus Yokenella, genus Rahnella, genus Raoultella, genus Lactococcus, genus Lactosphaera, genus Lactobacillus, genus Lachnospira, genus Rathayibacter, genus Rhabdochromatium, genus Labrys, genus Ralstonia, genus Rarobacter, genus Lamprocystis, genus Lamprobacter, genus Lampropedia, genus Riemerella, genus Rickettsia, genus Rickettsiella, genus Rikenella, genus Listeria, genus Listonella, genus Lysobacter, genus Rhizobacter, genus Rhizobium, genus Rhizomonas, genus Lyticum, genus Limnobacter, genus Lewinella, genus Ruegeria, genus Rugamonas, genus Lucibacterium, genus Luteimonas, genus Luteococcus, genus Runella, genus Rubrivivax, genus Rubrimonas, genus Rubrobacter, genus Ruminococcus, genus Ruminobacter, genus Leifsonia, genus Leclercia, genus Lechevalieria, genus Legionella, genus Renibacterium, genus Levinea, genus Leptospira, genus Leptospirillum, genus Leptothrix, genus Leptotrichia, genus Leptonema, genus Leminorella, genus Lentzea, genus Leucothrix, genus Leuconostoc, genus Leucobacter, genus Lawsonia, genus Lautropia, genus Lochalimaea, genus Roseateles, genus Roseinatronobacter, genus Roseibium, genus Roseivivax, genus Roseococcus, genus Roseospira, genus Roseospirillum, genus Roseobacter, genus Roseovarius, genus Roseomonase, genus Roseburia, genus Rhodanobacter, genus Rothia, genus Rhodococcus, genus Rhodothermus, genus Rhodocyclus, genus Rhodocista, genus Rhodopseudomonas, genus Rhodospira, genus Rhodospirillum, genus Rhodothalassium, genus Rhodobaca, genus Rhodobacter, genus Rhodobium, genus Rhodovibrio, genus Rhodopila, genus Rhodoferax, genus Rhodoplanes, genus Rhodovulum, genus Rhodomicrobium, genus Lonepinella, genus Weissella, genus Waddlia and the like.
Those which can also be exemplified are eukaryotic microorganisms such as genus Issatchenkia, Candida, genus Cryptococcus, genus Kluyverintces, genus Kloeckera, genus Saccharomycodes, genus Saccharomyces, genus Zygosaccharomyces, genus Shizosaccharomyces, genus Sirobasidium, genus Strigmatomyces, genus Sporidobolus, genus Sporobolomyces, genus Dekkera, genus Debaryomyces, genus Trichosporon, genus Trigonopsis, genus Torulaspora, genus Tremella, genus Nadsonia, genus Nematospora, genus Hanseniaspora, genus Pichia, genus Fibulobasidium, genus Filobasidium, genus Filobasidiella, genus Bullera, genus Brettanomyces, genus Holtermannia, genus Malassezia, genus Metschnikowia, genus Lipomyces, genus Leucosporidium, genus Rhodosporidium, genus Rhodotorula, genus Acaulopage, genus Aquamortierella, genus Asellaria, genus Amoebidium, genus Amoeophilus, genus Arundinula, genus Utharomyces, genus Echinosporangium, genus Enterobryus, genus Endogone, genus Entomophthora, genus Kickxella, genus Genistellospora, genus Choanephora, genus Coemansia, genus Cochlonema, genus Conidiobolus, genus Saksenaea, genus Thamnidium, genus Thamnocephalis, genus Dispira, genus Dimargaris, genus Syncephalastrum, genus Syncephalis, genus Zoopage, genus Sclerocystis, genus Smittium, genus Basidiobolus, genus Parataeniella, genus Paramoebidium, genus Palavascia, genus Harpella, genus Piptocephalis, genus Pilobolus, genus Phycomyces, genus Blakeslea, genus Hesseltinella, genus Helicocephalum, genus Mycotypha, genus Radiomyces, genus Legeriomyces, genus Rhopalomyces, genus Acrasis, genus Acytostelium, genus Arcyria, genus Echinostelium, genus Echinosteliopsis, genus Oligonema, genus Cavostelium, genus Guttulinopsis, genus Clastoderma, genus Cribraria, genus Coenonia, genus Copromyxa, genus Comatricha, genus Colloderma, genus Dianema, genus Dictyostelium, genus Didymium, genus Diderma, genus Stemonitis, genus Thraustochytrium, genus Ceratiomyxa, genus Ceratiomyxella, genus Trichia, genus Physarum, genus Plasmodiophrora, genus Fuligo, genus Bursulla, genus Prorostelium, genus Protosporangium, genus Hemitrichia, genus Perichaena, genus Polysphondylium, genus Polymyxa, genus Labyrinthula, genus Lamproderma, genus Lycogala, genus Licea, genus Wardmyces, genus Actinopelte, genus Asterosporium, genus Arthrinium, genus Alternaria, genus Oidium, genus Clabosporium, genus Cladobotryum, genus Graphium, genus Colletotrichum, genus Sclerotium, genus Stagonospora, genus Stibella, genus Tubercularia, genus Bactridium, genus Pycnothrium, genus Phaeoisaria, genus Pestalozziella, genus Rhizoctonia, genus Rhinocladiella, genus Leptothyrium, genus Achlyogeton, genus Anisolpidium, genus Albugo, genus Ectrogella, genus Olipidium, genus Olpidiopsis, genus Catenaria, genus Chytridium, genus Cladochytrium, genus Coelomomyces, genus Gonapodya, genus Saprolegnia, genus Sirolpidium, genus Synchytrium, genus Haliphthoros, genus Harpochytrium, genus Pythium, genus Hyphochytrium, genus Physoderma, genus Phlyctidium, genus Blastocladia, genus Peronospora, genus Peronophythora, genus Micormycopsis, genus Megachytrium, genus Monoblepharis, genus Lagenidium, genus Rhizidiomyces, genus Rhizidium, genus Rhipidium, genus Leptomitus, genus Leptolegniella, genus Acremonium, genus Aspergillus, genus Absidia, genus Arachniotus, genus Arthrobotrys, genus Ulocladium, genus Echinobotryum, genus Exophiala, genus Epicoccum, genus Oidiodendron, genus Oedocephalum, genus Aureobasidium, genus Curvularia, genus Candelabrella, genus Cunninghamella, genus Gymnoascus, genus Cladosporium, genus Graphium, genus Gliocladium, genus Chrysosporium, genus Chromelosporium, genus Geotrichum, genus Geomyces, genus Chaetomium, genus Geniculifera, genus Gonatobotrysm, genus Coniothyrium, genus Circinella, genus Zygorhynchus, genus Diplodia, genus Cylindrocarpon, genus Scopulariopsis, genus Stachybotrys, genus Stemphylium, genus Sporothrix, genus Sepedonium, genus Dactylella, genus Talaromyces, genus Dratomyces, genus Trichurus, genus Trichocladium, genus Trichothecium, genus Trichoderma, genus Trichophyton, genus Nigrospora, genus Verticicladiella, genus Verticillium, genus Paecilomyces, genus Pithomyces, genus Bipolaris, genus Pyrenochaeta, genus Phialocephala, genus Phialophora, genus Phoma, genus Fusarium, genus Pestalotiopsis, genus Penicillium, genus Botrytis, genus Microsporum, genus Myrothecium, genus Mucor, genus Memnoniella, genus Monacrosporium, genus Monilia, genus Mortierella, genus Eupenicillium, genus Eurotium, genus Rhizopus, genus Leptographium, genus Robillarda, genus Austroboletus, genus Auricularia, genus Auriscalpium, genus Agaricus, genus Agrocybe, genus Asterophona, genus Astraeus, genus Aseroe, genus Anellaria, genus Amauroderma, genus Amanita, genus Armillaria, genus Armillariella, genus Alcuria, genus Ischnoderma, genus Inocybe, genus Inonotus, genus Ileodictyon, genus Wynnea, genus Verpa, genus Volvariella, genus Urnula, genus Echinodontium, genus Exidia, genus Elfvingia, genus Oudemansiella, genus Omphalina, genus Onnia, genus Catathelasma, genus Ganoderma, genus Camarophyllus, genus Chalciporus, genus Galerina, genus Calocera, genus Calostoma, genus Cantharellus, genus Cantharellula, genus Cyathus, genus Cyclomyces, genus Cystoderma, genus Cyptotrama, genus Cymatoderma, genus Gymnopilus, genus Kuehneromyces, genus Gyrodon, genus Gyroporus, genus Gyromitra, genus Guepinia, genus Xanthoconium, genus Xylaria, genus Xerocomus, genus Xeromphalina, genus Cudonia, genus Clavatia, genus Clavaria, genus Clavariadelphus, genus Clavicorona, genus Clavulina, genus Clavulinopsis, genus Craterellus, genus Clathrus, genus Clitocybe, genus Clitopilus, genus Crinipellis, genus Grifola, genus Cryptoderma, genus Cryptoporus, genus Crucibulum, genus Creolophus, genus Crepidotus, genus Chroogomphus, genus Chlorosplenium, genus Geastrum, genus Geolossum, genus Cotylidia, genus Conocybe, genus Kobayashia, genus Coprinus, genus Gomphidius, genus Gomphus, genus Coriolus, genus Cordyceps, genus Cortinarius, genus Coltricia, genus Collybia, genus Sarcoscypha, genus Sarcodon, genus Sarcodontia, genus Suillus, genus Schizophyllum, genus Squamanita, genus Scutellinia, genus Scleroderma, genus Stereum, genus Strobilomyces, genus Stropharia, genus Spathularia, genus Sparassis, genus Daedaleopsis, genus Dacryomyces, genus Daldinia, genus Dictyophora, genus Tylopilus, genus Tyromyces, genus Descolea, genus Thelephora, genus Tulostoma, genus Trametes, genus Trichoglossum, genus Torichocoma, genus Tricoloma, genus Tricholomopsis, genus Tremella, genus Tremellodon, genus Naematoloma, genus Nidula, genus Neobulgaria, genus Baeospora, genus Paxillus, genus Battarea, genus Panaeolus, genus Panus, genus Panellus, genus Bankera, genus Hygrocybe, genus Hygrophorus, genus Hygrophoropsis, genus Bisporella, genus Pisolithus, genus Hydnum, genus Hydnellum, genus Hypsizygus, genus Piptoporus, genus Hypoxylon, genus Hymenochaete, genus Hirschioporus, genus Pyrrhoderma, genus Favolus, genus Phaeolus, genus Phaeolepiota, genus Phallus, genus Fistulina, genus Phyllotopsis, genus Phylloporus, genus Filoboletus, genus Phellinus, genus Fomitopsis, genus Fomes, genus Pholiota, genus Psathyrella, genus Psilocybe, genus Pseudocolus, genus Pseudohiatula, genus Prerula, genus Flammulina, genus Pulveroboletus, genus Bulgaria, genus Pluteus, genus Pleurocybella, genus Pleurotus, genus Plectania, genus Phlogiotis, genus Peziza, genus Penicilliopsis, genus Hebeloma, genus Hericium, genus Helvella, genus Podostroma, genus Polyozellus, genus Polyporus, genus Polyporellus, genus Holtermannia, genus Boibitius, genus Porphyrellus, genus Boletinus, genus Boletellus, genus Boletus, genus Boletopsis, genus Porodisculus, genus Bondarzewia, genus Macrocystidia, genus Macropodia, genus Macrolepiota, genus Marasmius, genus Marasmiellus, genus Microporus, genus Mycena, genus Mitrula, genus Mutinus, genus Melanoleuca, genus Merulius, genus Morchella, genus Laetiporus, genus Lactarius, genus Lasiosphaera, genus Laccaria, genus Ramaria, genus Lampteromyces, genus Lyophyllum, genus Rigidoporus, genus Lycoperdon, genus Rhizina, genus Lysurus, genus Limacella, genus Linder, genus Russula, genus Leucocoprinus, genus Leucopaxillus, genus Leotia, genus Resupinatus, genus Leccinum, genus Lepiota, genus Lepista, genus Lenzites, genus Lentaria, genus Lentinus, genus Lentinula, genus Lentinellus, genus Rozites, genus Rhodocybe, genus Rhodotus, genus Rhodophyllus and the like.
A microorganism listed above which has an ability of producing an inventive coenzyme-binding glucose dehydrogenase has been deposited under its accession number to IFO, ATCC and the like, and can be obtained from known distributors and corporations. Such a microorganism may for example be a eukaryotic microorganism, more preferably mycotic microorganism. It is also possible to use the microorganism which is designated as “97508” and was deposited under FERM BP-08578 to International Patent Organism Depositary of National Institute of Advanced Industrial Science and Technology.
In one embodiment of the method for producing the inventive coenzyme-binding glucose dehydrogenase, a microorganism having an ability of producing the inventive coenzyme-binding glucose dehydrogenase is cultured in a nutrition medium, in which the coenzyme-binding glucose dehydrogenase is allowed to be produced and accumulated, and then recovered to yield a protein which is the coenzyme-binding glucose dehydrogenase and its salt.
The deposited inventive strain FERM BP-08578, a coenzyme-binding glucose dehydrogenase derived therefrom, and a method for obtaining the enzyme are described below.
1. Physicochemical Characteristics of FERM BP-08578-Derived Enzyme
(1) Effect: On the basis of the classification by International Union of Biochemistry (IUB), the inventive enzyme corresponds to EC1.1.99.10, and catalyzes the reaction shown below which oxidizes a hydroxyl group in the 1st-position of glucose in the presence of an electron acceptor to yield glucono-6-lactone.
Glucose+Electron acceptor→Glucono-δ-lactone+reduced electron acceptor
In the invention, the electron acceptor may for example be phenazine methosulfate, 1-methoxy-5-methylphenazinium methyl sulfate, 2,6-dichlorophenolindophenol, ferricyanides and the like.
(2) Substrate specificity: The relative reactivity (substrate specificity) of the inventive enzyme when using D-glucose and other substrates (all at the final concentration of 333 mM except for D-cellobiose at 193 mM, D-trehalose and D-raffinose at 121 mM) by the activity measurement method 1 described below are shown in Table 1. The relative reactivity (substrate specificity) when using D-glucose and maltose at the final concentrations of 550 mM and 100 mM are shown in Table 2. A higher activity was observed on D-glucose, while lower activity were observed on D-mannose, 1,5-anhydro-D-glucitol, D-cellobiose, D-trehalose, maltose, D-galactose, D-glucose-6-phosphate and D-fructose. Almost no activity was observed on L-arabinose, lactose, D-sorbitol, gluconic acid, sucrose, D-mannitol, L-sorbose, D-ribose, L-rhamnose, D-glucose-1-phosphate, D-raffinose, ethanol or glycerol.
(3) Optimum pH: pH7.0 to pH9.0.
(4) pH for stability: pH4.5 to pH8.5.
(5) Optimum temperature: Approximately 55° C.
(6) Thermal stability: Stable at 50° C. or below.
(7) Molecular weight: About 130 kDa when measured by a gel filtration method, and about 85 kDa when measured by a sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
(8) Km value: 49.7 mM (D-glucose).
(9) Isoelectric point: The isoelectric point (pI) of the coenzyme-binding glucose dehydrogenase measured by an isoelectric focusing was about 4.4.
(10) Inhibitor: When each additive was added at 1 mM as a final concentration to the activity measurement method 1 described below and the activity was measured, an inhibitory effect of each additive was observed when comparing with the control group as shown in Table 3. When adding 1,10-phenanthroline (dissolved in methanol) at each final concentration to the activity measurement method 1 described below, the inhibitory effect shown in Table 4 was observed. The activity of this enzyme was inhibited potently by heavy metal ions (Ag+, Cu2+, Hg2+), and inhibited by 60% or higher by 1,10-phenanthroline, proflavin and Mn2+.
(11) Coenzyme: Flavin adenine dinucleotide.
The amino acid sequence of the coenzyme-binding glucose dehydrogenase and the base sequence of a gene encoding it are also encompassed by the invention.
For producing the inventive coenzyme-binding glucose dehydrogenase, a microorganism for producing the coenzyme-binding glucose dehydrogenase may be any microorganism as far as it can produce the inventive coenzyme-binding glucose dehydrogenase, and the enzyme can efficiently be produced by using a microorganism, preferably a eukaryotic microorganism, more preferably a mycotic microorganism. It is especially preferred to use the microorganism which is designated as “97508” and was deposited under FERM BP-08578 to International Patent Organism Depositary of National Institute of Advanced Industrial Science and Technology. The deposited strain was isolated from a soil by Applicants, and has the mycological characteristics as described below. In the invention, any variant of the strain mentioned above may also be employed. Such a variant can be obtained for example by the irradiation with an ultraviolet light or X-ray or the treatment with a chemical modifier (NTG and the like).
2. Mycological Characteristics of FERM BP-08578
(1) Morphological characteristics: The morphological profile of the present strain when observed by an optical microscope after allowed to grow on a potato dextrose agar medium is described below. Each mycelium has a width of 2 μm to 4 μm, and has a regular septum. Most of the mycelia grow linearly, and have branches with almost no swollen mycelia being observed. Several mycelia are gathered together to form a mycelial bundle. The mycelial width is almost constant. The surface of a mycelium is smooth and the septum is slightly thick. A crystalloid is formed around the root of the aerial mycelia. No clamp connection is formed. The mycotic body formed in 2-week culture exhibited no formation of any sexual or asexual reproductive organs, and no oidia or thick-walled spores are present.
(2) Growth condition in various culture media: On all agar plates, each mycelium is in a form of a fluff. The aerial mycelium shade is white. On the potato dextrose agar plate, the backside color is pale orange to orange. The growth magnitude is medium, and a colony after culturing at 25° C. for 1 week has a diameter of 30 mm to 35 mm on the potato dextrose and oatmeal agar plates, and 37 mm to 38 mm on the malt extract agar plate. The production of soluble pigments of a pale yellow color on the potato dextrose agar plate and a slightly reddish to grey-reddish color on the oatmeal agar plate was noted. The mycotic body formed in 2-week culture exhibited no formation of reproductive organs such as a conidiophore, and no exudate was produced.
(3) Physiological characteristics: The present strain is an aerobic one and has an optimum growth temperature of about 37° C. on the potato dextrose agar plate.
3. Taxonomical Characteristics of FERM BP-08578
Based on the characteristics described above, the deposited strain “97508” was characterized with referring to Ainsworth & Bisby's Dictionary of the Fungi, 7th edition (Ed. by Hawksworth, Sutton, Ainsworth). As a result of this characterization, the deposited strain was revealed to be a microorganism classified into the genus Aspergillus. Then its genome sequence was subjected to BLAST homology search. An 18S rDNA fragment was amplified using a genome DNA as a template by PCR method, and then sequence of the purified PCR product was analyzed. In order to search for an analogous base sequence through GenBank (GenBank/EMBL/DDBJ international DNA sequence database), BLAST (Altschul et al., 1997) homology search was conducted, and revealed that this deposited strain “97508” is Aspergillus terreus.
In one embodiment of the method for producing a coenzyme-binding glucose dehydrogenase according to the invention, the microorganism described above is cultured to allow the coenzyme-binding glucose dehydrogenase to be expressed or produced by the microorganism in internal and/or external of its fungus body.
For the culture of the microorganism in the invention, any ordinary culture medium for microorganism may be used. Such medium may include a synthetic or natural medium, as long as it contains suitable amounts of carbon sources, nitrogen sources, inorganic substances and other trace elements required by the microorganism. The carbon sources may be glucose, sucrose, dextrin, starch, glycerin, syrup and the like. The nitrogen sources may be inorganic salts such as ammonium chloride, ammonium nitrate, ammonium sulfate and ammonium phosphate, amino acids such as DL-alanine and L-glutamic acid, as well as nitrogen-containing natural materials such as peptone, meat extract, yeast extract, malt extract, corn steep liquor and the like. The inorganic materials may for example be monosodium phosphate, disodium phosphate, monopottasium phosphate, dipotassium phosphate, magnesium sulfate, ferric chloride and the like.
The culture in order to obtain the inventive coenzyme-binding glucose dehydrogenase is conducted preferably in an aerobic condition for example by a shaking or aerating culture at a temperature of 25° C. to 60° C. at a pH of 5 to 8. The culture period ranges preferably from 2 days to 4 days. As a result of such a culture, the coenzyme-binding glucose dehydrogenase can be produced and accumulated in the culture, especially in a culture fluid. By using this culture method, the coenzyme-binding glucose dehydrogenase can be produced by the microorganism and accumulated also internal fungus body. Subsequently, the coenzyme-binding glucose dehydrogenase can be recovered from the culture by means of an ordinary protein purification method. Such a method may be a method comprising incubating the microorganism followed by removing the microorganism for example by a centrifugation to obtain a supernatant, or a method comprising incubating the microorganism, recovering the cultured microorganism from the culture fluid by a centrifugation, crushing the cultured microorganism by a suitable method, and then isolating a supernatant for example by a centrifugation from the pelletized microorganism fluid. The coenzyme-binding glucose dehydrogenase contained in such a supernatant can be purified by a combination of suitable purification procedures such as salting out, solvent sedimentation, dialysis, ion exchange chromatography, hydrophobic adsorption chromatography, gel filtration, affinity chromatography, electrophoresis and the like.
In the culture for obtaining the inventive coenzyme-binding glucose dehydrogenase, a solid medium can be also used. The method for such a culture is not limited particularly, and may for example be a static culture, or a dynamic culture involving a continuous agitation of the culture, such as a rotational culture or fluidized bed culture, with a static culture being preferred due to a less expensive investment in equipment. Thereafter, as a method of obtaining the coenzyme-binding glucose dehydrogenase from the culture, an ordinary protein purification method can be adopted. That is, the culture is combined with water or other extraction medium and shaken, made free of any solid components such as bran by means of a centrifugation or filtration, thereby yielding an extract. It is also possible that the coenzyme-binding glucose dehydrogenase accumulated in the fungus bodies can be recovered by grinding the culture residue after obtaining the extract described above together with a an abrasive compound such as a sea sand, followed by adding water to extract the coenzyme-binding glucose dehydrogenase released from the fungus bodies. In order to obtain the entire coenzyme-binding glucose dehydrogenase, the entire culture is ground with an abrasive compound such as a sea sand, followed by adding water to extract both of the coenzyme-binding glucose dehydrogenase released from the fungus bodies and the coenzyme-binding glucose dehydrogenase secreted into the culture all at once. The coenzyme-binding glucose dehydrogenase contained in such a supernatant can be purified by a combination of suitable purification procedures such as salting out, solvent sedimentation, dialysis, ion-exchange chromatography, hydrophobic adsorption chromatography, gel filtration, affinity chromatography, electrophoresis and the like.
Alternatively, the inventive coenzyme-binding glucose dehydrogenase may also be a synthetic coenzyme-binding glucose dehydrogenase or a recombinant coenzyme-binding glucose dehydrogenase obtained by a gene engineering technology. Those skilled in the art can obtain the coenzyme-binding glucose dehydrogenase readily based on the disclosure of the protein or its salt derived from the physicochemical characteristics of the inventive coenzyme-binding glucose dehydrogenase. For example, the coenzyme-binding glucose dehydrogenase can be extracted from a microorganism including a fungi or a naturally occurring material such as an animal or plant, or can be obtained synthetically with referring to the amino acid sequence or the base sequence of the gene encoding it. Moreover, it is also possible to produce the coenzyme-binding glucose dehydrogenase industrially using a gene engineering method in which a gene segment of the coenzyme-binding glucose dehydrogenase gene is inserted into a known expression vector such as a commercial expression vector and then the resultant plasmid is used to transform a host such as Escherichia coli to obtain a transformant which is then cultured to obtain a target coenzyme-binding glucose dehydrogenase.
For measuring the activity of the inventive enzyme, the enzyme is diluted appropriately to a final concentration of 0.1 to 1 unit/mi. The enzymatic activity unit of the enzyme is the enzymatic activity enabling the oxidation of 1 μmol glucose per minute. The enzymatic activity of the inventive coenzyme-binding glucose dehydrogenase can be measured by the method shown below.
(i) Enzymatic Activity Measurement Method 1
To a 3-ml quartz cell (light path length: 1 cm), 1.0 ml of 0.1M potassium phosphate buffer (pH7.0), 1.0 ml of 1.0M D-glucose, 0.1 ml of 3 mM 2,6-dichlorophenolindophenol (hereinafter referred to as DCIP), 0.2 ml of 3 mM 1-methoxy-5-methylphenazinium methyl sulfate and 0.65 ml of water are added, which is followed by setting in a thermostat cell holder-mounted spectrophotometer and incubated at 37° C. for 5 minutes and then supplemented with 0.05 ml of the enzyme solution, and then measuring the change in the absorption of DCIP at 600 nm (AABS/min). Based on a molar extinction coefficient of DCIP at pH7.0 being regarded as 16.3×103 cm−1M−1 and the enzymatic activity corresponding to the reduction of 1 μmol of DCIP per minute being equivalent to 1 unit of the enzymatic activity, the enzymatic activity was determined from the change in the absorption on the basis of the following equation.
Enzymatic activity (unit/ml)=(−ΔABS/16.3)×(3.0/0.05)×Enzyme dilution rate
(ii) Enzymatic Activity Measurement Method 2
It was carried out that 3.4 μl of 1.0M potassium phosphate buffer (pH7.0), 0.1 ml of 1.0M D-glucose and 86.6 μl of 20 mM DCIP were incubated at 37° C. for 5 minutes, supplemented with 0.01 ml of an enzyme solution, stirred, reacted for 5 minutes, incubated at 100° C. for 3 minutes to quench the reaction. Thereafter, 0.19 ml of 100 mM glycine-sodium buffer (pH13.0), 0.01 ml of 2.0N potassium hydroxide were added, incubated at 37° C. for 10 minutes to convert D-gluconic acid in the solution into D-glucono-6-lactone, and thereafter combined with 0.39 ml of a 100 mM Tris-HCl buffer (pH7.5) and 0.01 ml of 1.0N hydrochloric acid to achieve a neutral pH. The D-gluconic acid in the solution was quantified using the D-gluconic acid/D-glucono-6-lactone measurement kit (Boehringer Mannheim). Since the enzymatic activity corresponding to the production of 1 μmol of D-glucono-δ-lactone per minute is equivalent substantially to 1 unit of this enzyme, this enzymatic activity was determined based on the amount of D-glucono-6-lactone produced.
The invention relates to a material production and an analytical application employing an inventive coenzyme-binding glucose dehydrogenase, and also relates to the use in the modification of pharmaceutical or food product materials. In one example, the use is made in a method for eliminating glucose in a sample containing a biological material using the coenzyme-binding glucose dehydrogenase as a reagent, a measurement method as well as in such a reagent or a reagent composition. The use is made also in a method for producing an organic compound using the inventive coenzyme-binding glucose dehydrogenase as well as in a basic ingredient therefor.
The inventive coenzyme-binding glucose dehydrogenase is the enzyme that catalyzes a reaction for oxidizing glucose in the presence of an electron acceptor. In the invention, the reaction mentioned above employs the inventive coenzyme-binding glucose dehydrogenase. Such a coenzyme-binding glucose dehydrogenase is not limited particularly, and is preferably a coenzyme-binding glucose dehydrogenase derived from a eukaryotic microorganism producing the coenzyme-binding glucose dehydrogenase, with a coenzyme-binding glucose dehydrogenase derived from a mycotic microorganism being preferred especially.
Now the description is made with regard to the application of the coenzyme-binding glucose dehydrogenase obtained according to the invention. Since the coenzyme-binding glucose dehydrogenase is the enzyme that catalyzes a reaction for oxidizing glucose in the presence of an electron acceptor, any application in which the change resulting from such a reaction can be utilized can be mentioned. For example, the coenzyme-binding glucose dehydrogenase can be used in a reagent for measuring or eliminating glucose in a sample containing a biological material. It is also possible to use in medical and clinical fields, and also in the material production and analysis employing the coenzyme-binding glucose dehydrogenase.
The inventive biosensor may be any sensor having a reaction layer containing the inventive coenzyme-binding glucose dehydrogenase as an enzyme. For example, the biosensor can be produced in a method wherein an enzymatic reaction layer formed thereon containing a hydrophilic polymer, a redox enzyme and an electron acceptor is brought into contact with an electrode system consisting of an action electrode, a counter electrode and a reference electrode is formed for example by a screen printing on an insulating board. When a substrate-containing sample solution is dropped onto the enzymatic reaction layer in this biosensor, the enzymatic reaction layer is dissolved to effect the reaction between the enzyme and the substrate, thereby reducing the electron acceptor. After completion of the enzymatic reaction, the reduced electron acceptor is oxidized electrochemically, whereupon the biosensor can measure the concentration of the substrate in the sample based on the resultant oxidation current value. Otherwise, a biosensor can be constructed so that the chromogenic intensity or pH change is detected. By using above mentioned biosensors, any of various materials can be measured by selecting the enzyme whose substrate is the target substance. For example, when the inventive coenzyme-binding glucose dehydrogenase is selected as an enzyme, a glucose sensor enabling the measurement of the concentration of glucose in a sample solution can be produced.
As the electron acceptor in the biosensor, a chemical substance having an excellent ability of transferring an electron can be employed. Such a chemical substance having an excellent ability of transferring an electron is generally a substance referred to as “electron carrier”, “mediator” or “oxidation/reduction(redox)-mediating agent”, such as the electron transfer and the redox-mediating agent listed in JP-W-2002-526759.
In the biosensor, an inexpensive potassium ferricyanide (potassium hexacyanoferrate (III)) is generally employed as an electron acceptor, and usually used at a final concentration of 1 mM or less. Nevertheless, the inventive coenzyme-binding glucose dehydrogenase enables a more sensitive measurement of D-glucose when using potassium ferricyanide at a concentration as high as 2 to 500 mM, more preferably 30 to 100 mM. A preferred embodiment of the inventive measurement method, measurement reagent, measurement compound, biosensor and the like is characterized by the use of potassium ferricyanide in its relevant measurement system at a final concentration of 2 to 500 mM.
The present invention is further described in the following Examples, by which the invention is not restricted without departing from its scope. In the following Examples, the quantification of a coenzyme-binding glucose dehydrogenase was conducted as described above.
100 ml of a culture medium (pH6.0) containing 1% glucose (WAKO PURE CHEMICAL), 2% defatted soybean (NIPPON SHOKUHAN), 0.5% of corn steep liquor (KYODO SHOJI) and 0.1% magnesium sulfate (Nacalai Tesque) was placed in a 500-ml culture flask, which was sterilized at 121° C. for 20 minutes, cooled, inoculated with a platinum loop of the deposited strain 97508, shaken at 30° C. for 88 hours to obtain a seed culture of the strain. 4 L of the culture medium having the composition similar to that described above but supplemented with an antifoam agent was added to a 5-L jar fermenter, which was sterilized at 121° C. for 30 minutes, cooled, inoculated with 40 ml of the seed culture described above, cultured at 28° C. for 31 hours with aerating and shaking to obtain a preliminary culture of the strain. Then, 160 L of the culture medium having the composition similar to that described above but supplemented with an antifoam agent was added to a 200-L jar fermenter, which was sterilized at 121° C. for 20 minutes, cooled, inoculated with 1.6 L of the preliminary culture described above, cultured at 28° C. for 41 hours with aerating and shaking. After completion of the culture, the culture fluid was centrifuged to obtain the supernatant.
By the following Steps 2.1 to 2.5, the coenzyme-binding glucose dehydrogenase was isolated.
2.1 Concentration
160 L of the culture supernatant of Example 1 was concentrated through an ultrafiltration membrane “Pellicon 2 Module” (Millipore), and transferred into a 20 mM potassium phosphate buffer (pH7.5) to obtain a crude enzyme solution.
2.2 Purification by Butyl-TOYOPEARL 650M (TOSOH) (First Process)
The abovementioned crude enzyme solution was prepared in 65%-saturated ammonium sulfate (pH7.5), and centrifuged to obtain a supernatant. This treated crude enzyme solution was loaded onto a Butyl-TOYOPEARL 650M column (diameter: 4.7 cm, height: 7.7 cm) which had previously been equilibrated with a 20 mM potassium phosphate buffer (pH7.5) containing 65% ammonium sulfate; and thereby allowing the enzyme is absorbed therein. This column was washed with the same buffer solution, and then the enzyme was allowed to be eluted with 20 mM potassium phosphate buffer (pH7.5) containing 30% ammonium sulfate to collect an active fraction. The enzyme was further eluted by a gradient elution starting from the same buffer to 20 mM potassium phosphate buffer (pH7.5), and pooled with the former active fraction.
2.3. Purification by DEAE-CELLULOFINE A-500 (SEIKAGAKU KOGYO)
The abovementioned active fraction was concentrated through an ultrafiltration membrane “Pellicon 2 Module”, desalted, and equilibrated with a 15 mM Tris-HCl buffer (pH8.5). This fraction was loaded onto a DEAE-CELLULOFINE A-500 column (diameter: 4.7 cm, height: 5.2 cm) which had previously been equilibrated with the same buffer solution, and the eluate was collected.
2.4 Purification by Butyl-TOYOPEARL 650M (TOSOH) (Second Process)
The abovementioned eluate was prepared in 65%-saturated ammonium sulfate (pH7.5), and centrifuged to obtain a supernatant. This supernatant was loaded onto a Butyl-TOYOPEARL 650M column (diameter: 4.7 cm, height: 3.6 cm) which had previously been equilibrated with a 20 mM potassium phosphate buffer (pH7.5) containing 65% ammonium sulfate; thereby allowing the enzyme is absorbed. This column was washed with the same buffer solution, and then the enzyme was allowed to be eluted with 20 mM potassium phosphate buffer (pH7.5) containing 30% ammonium sulfate to collect an active fraction.
2.5 Purification by TSKgel G3000SW (TOSOH)
The abovementioned active fraction was concentrated through a pencil type membrane concentration module “ACP-0013” (ASAHI KASEI), desalted, and equilibrated with 50 mM potassium phosphate buffer (pH5.5) containing 0.2M sodium chloride. This fraction was loaded onto a TSKgel G3000SW (diameter: 2.15 cm, height: 60 cm) which had previously been equilibrated with the buffer described above, and the enzyme was eluted with the same buffer to obtain an active fraction. The active fraction was concentrated through a centriplus 10 (Amicon), desalted, and transferred into a 50 mM citric acid-sodium phosphate buffer (pH5.5). The resultant enzyme approximately had a specific activity of 1,100 unit/mg, and a purification degree of about 170 times greater than that of the crude enzyme solution.
The coenzyme-binding glucose dehydrogenase isolated in Example 2 described above was examined for its effect, optimum pH, pH for stability, optimum temperature, thermal stability, substrate specificity, molecular weight, inhibitor and coenzyme.
3.1 Effect
The coenzyme-binding glucose dehydrogenase was reacted with 500 mM D-glucose in the presence of 8.66 mM DCIP, and the reaction product was quantified using D-gluconic acid/D-glucono-8-lactone measurement kit. As a result, the production of D-gluconic acid was identified, and it was revealed that the inventive coenzyme-binding glucose dehydrogenase is the enzyme that catalyzes a reaction for oxidizing a hydroxyl group in the I-position of D-glucose.
3.2 Optimum pH
The buffer solution according to the Enzymatic activity measurement method 2 was replaced with the citric acid-sodium phosphate buffer (pH4.0 to 5.5), potassium phosphate buffer (pH6.5 to 7.5), Tris-HCl buffer (pH8.0 to 9.0) or glycine-sodium hydroxide buffer (pH9.5 to 10.0) (each 17 mM as a final concentration), and the enzymatic activity of the purified enzyme was measured at various pH ranges similarly to Enzymatic activity measurement method 2 (
3.3 pH for Stability
The coenzyme-binding glucose dehydrogenase was dissolved in each 50 mM buffer, i.e., citric acid-sodium phosphate buffer (pH3.2 to 6.4), potassium phosphate buffer (pH6.3 to 6.9), Tris-HCl buffer (pH7.3 to 8.6) or glycine-sodium hydroxide buffer (pH9.1 to 11.4) and kept at 40° C. for 60 minutes, and then the enzymatic activity was examined by the method according to the activity measurement method 1, and a ratio of residual enzymatic activity was analyzed (
3.4 Optimum Temperature
The coenzyme-binding glucose dehydrogenase was dissolved in 50 mM citric acid-sodium phosphate buffer (pH5.5) and examined for the enzymatic activity over the range from 30° C. to 62° C. by the Enzymatic activity measurement method 1 described above (
3.5 Thermal Stability
The coenzyme-binding glucose dehydrogenase was dissolved in 50 mM citric acid-sodium phosphate buffer (pH5.5), kept at several points of the temperature ranging from 0° C. to 55° C. for 15 minutes, and then examined for the enzymatic activity by the Enzymatic activity measurement method 1, and the ratio (%) of residual enzymatic activity was analyzed (
3.6 Substrate Specificity and Km Value
Employing each of D-glucose and other substrates (each at 333 mM as a final concentration, except for D-cellobiose at 193 mM, D-trehalose and D-raffinose at 121 mM), the enzymatic activity of this enzyme was measured by the Enzymatic activity measurement method 1. The activity on each substrate is represented as a relative value to the activity of this enzyme on D-glucose being regarded as 100%, and shown in Table 1.
Similarly, the relative reactivities (enzymatic activity) on D-glucose and maltose each at two final concentrations, i.e. 550 mM and 100 mM, were measured. The results are represented as relative values based on the value on D-glucose.
As evident from these results, the coenzyme-binding glucose dehydrogenase acts potently on D-glucose, and weakly on D-mannose, 1,5-anhydro-D-glucitol, D-cellobiose, D-trehalose, maltose, D-galactose, D-glucose-6-phosphate and D-fructose. This enzyme exhibited almost no effect on L-arabinose, lactose, D-sorbitol, gluconic acid, sucrose, D-mannitol, L-sorbose, D-ribose, L-rhamnose, D-glucose-1-phosphate, D-raffinose, ethanol or glycerol. The Km value of this enzyme was 49.7 mM on D-glucose.
3.7 Molecular Weight and Subunit Molecular Weight
The coenzyme-binding glucose dehydrogenase was dissolved in a 50 mM potassium phosphate buffer (pH7.5) containing 0.2M NaCl, and analyzed on a TSKgel-G3000SW (diameter: 0.75 cm, length: 60 cm, TOSOH) using the same buffer solution as a mobile phase. When using a molecular weight marker (Oriental Yeast) as an index, the molecular weight of the coenzyme-binding glucose dehydrogenase was revealed to be about 130 kDa. Using a 12.5% polyacrylamide gel, the inventive coenzyme-binding glucose dehydrogenase was subjected to an SDS-polyacrylamide gel electrophoresis (SDS-PAGE) according to the method by Laemmli et al (Nature, (1970) 227:680-685). After the running, the gel was stained with Coomassie brilliant blue, and the mobility was compared with that of the molecular weight marker (Amersham Pharmacia Biotech), which revealed that the subunit molecular weight of the inventive coenzyme-binding glucose dehydrogenase was about 85 kDa.
3.8 Inhibitor
Each of the various additives shown in Table 3 was added as an inhibitor at 1 mM as a final concentration to the reaction system of the Enzymatic activity measurement method 1, and the activity of the coenzyme-binding glucose dehydrogenase was measured by the Enzymatic activity measurement method 1. In a control group, the procedure similar to that of Enzymatic activity measurement method 1 was conducted except for adding no additives shown in Table 3. Based on the enzymatic activity observed in the control group being regarded as 100%, the activity in the presence of each additive was calculated as a relative activity, the difference of which from the control group activity was regarded as a % inhibitory effect. As a result, the inhibitory effect shown in Table 3 was observed.
On the other hand, in the Enzymatic activity measurement method 1 described above, 1,10-phenanthroline respectively dissolved in methanol at 1 mM, 5 mM, 10 mM, 25 mM and 50 mM as final concentrations was added, and the activity of the inventive coenzyme-binding glucose dehydrogenase was measured in accordance with the Enzymatic activity measurement method 1. The final concentration of methanol relative to each reaction system was 10% (v/v). In a control group, methanol was added in the Enzymatic activity measurement method 1 at 10% (v/v) as a final concentration. The results are shown in Table 4. It was revealed that the inhibitory effect of 1,10-phenanthroline was as high as 62.0% at 1 mM, 76% at 5 mM, 85% at 10 mM, 91% at 25 mM and 95% at 50 mM as final concentrations of 1,10-phenanthroline.
The inhibitory effect on the inventive coenzyme-binding glucose dehydrogenase varied depending on the type of the additive, and was the highest in the presence of heavy metal ion (such as Ag+, Cu2+ and Hg2+), and was 60% or more in the presence of 1,10-phenanthroline, proflavin and Mn2+.
3.9. Coenzyme
The inventive coenzyme-binding glucose dehydrogenase solution was supplemented with D-glucose and subjected to the absorption analysis, which indicated the disappearance of the maximum absorptions observed at 385 nm and 465 nm in response to the supplement, revealing that the coenzyme was flavin adenine dinucleotide. These maximum absorptions are specific to FAD, and it was not observed in a control group reaction system constructed by excluding FAD only.
The coenzyme-binding glucose dehydrogenase derived from the deposited strain 97508 purified in Example 2 described above was employed, and the absorption reduction rate was measured using D-glucose at the concentration ranging from 0.333 to 33 mM instead of 333 mM D-glucose in the Enzymatic activity measurement method 1. Thus, the transition in the absorption was measured at each D-glucose concentration of 0.333 mM, 0.5 mM, 1 mM, 2 mM, 5 mM, 6.67 mM, 10 mM, 20 mM and 33 mM. The results of the measurement are shown in
As a result, a calibration curve (correlation coefficient r=0.997) was obtained; thereby, it was apparent that the quantification of D-glucose employing the coenzyme-binding glucose dehydrogenase is possible.
The coenzyme-binding glucose dehydrogenase derived from the deposited strain 97508 purified in Example 2 described above was employed to measure D-glucose by an enzyme-immobilizing electrode. A glassy carbon (GC) electrode on which 3.4 U of this enzyme was immobilized was employed to measure the response current to the glucose concentration. In an electrolytic cell, 2.7 ml of 100 mM sodium phosphate buffer (pH7.0) and 0.3 ml of 1M aqueous solution of potassium hexacyanoferrate (III) (potassium ferricyanide) were added. The GC electrode was connected to the potentiostat BAS100B/W (BAS), and the solution was stirred at 40° C. in each condition of argon saturation, oxygen saturation and air saturation while applying +500 mV to the silver-silver chloride reference electrode. 30 μl of a 1M D-glucose solution was added to these systems, and the current value in the stationary phase was measured. The same amount of the 1M D-glucose solution was further added, and the current value was measured, these procedure being repeated each three times. The resultant current values vs the known glucose concentrations (about 10, 20, 30 and 40 mM) were plotted to obtain a calibration curve (
Analogous to Example 5, the concentration of glucose in a serum was measured by the enzyme-immobilizing electrode using the control serum I WAKO B (WAKO PURE CHEMICAL). In an electrolytic cell, 2.4 ml of 100 mM sodium phosphate buffer (pH7.0) and 0.3 ml of 1M aqueous solution of potassium hexacyanoferrate (III) (potassium ferricyanide) were added, and the serum was added when the current value became stationary and the current value was measured. Similarly, the D-glucose solutions of known concentrations were measured to obtain a calibration curve. The glucose concentration in the serum was identified by the calibration curve method to be 4.5 mM, which was in agreement with the concentration of the glucose identified by the hexokinase-glucose-6-phosphate dehydrogenase method. Accordingly, it was revealed that the quantification of D-glucose in serum by the enzyme-immobilizing electrode employing the coenzyme-binding glucose dehydrogenase employed in the invention is possible.
According to the present invention, it became possible to provide a soluble coenzyme-binding glucose dehydrogenase whose activity on altose is 5% or less and which is inhibited by 1,10-phenanthroline. Furthermore, a method for producing the coenzyme-binding glucose dehydrogenase suitable to an industrial production and a microorganism producing therefor are also provided. As a result, it becomes possible to apply the coenzyme-binding glucose dehydrogenase to an industrial application, and more particularly, it becomes possible to measure the blood sugar level even in a diabetes patient receiving an infusion containing maltose. Also by using the inventive coenzyme-binding glucose dehydrogenase, a trace amount of the glucose can be measured even with a glucose sensor, thus enabling the utility. It also becomes possible to use in a material production or analysis including a method for measuring or eliminating glucose in a sample using the coenzyme-binding glucose dehydrogenase as well as a method for producing an organic compound, thereby providing a highly utilizable enzyme, which enables use for modifying a material in the fields of pharmaceuticals, clinical studies and food products.
| Number | Date | Country | Kind |
|---|---|---|---|
| 2002-373297 | Dec 2002 | JP | national |
| Number | Name | Date | Kind |
|---|---|---|---|
| 4767785 | Georgieff et al. | Aug 1988 | A |
| 5120420 | Nankai et al. | Jun 1992 | A |
| 5286362 | Hoenes et al. | Feb 1994 | A |
| 5364770 | Berka | Nov 1994 | A |
| 5413690 | Kost et al. | May 1995 | A |
| 5602018 | Kopetzki et al. | Feb 1997 | A |
| 5762770 | Pritchard et al. | Jun 1998 | A |
| 6059946 | Yukawa et al. | May 2000 | A |
| 6071391 | Gotoh et al. | Jun 2000 | A |
| 6100037 | Phillips et al. | Aug 2000 | A |
| 6103509 | Sode et al. | Aug 2000 | A |
| 6338790 | Feldman et al. | Jan 2002 | B1 |
| 6558920 | Hata et al. | May 2003 | B1 |
| 6592745 | Feldman et al. | Jul 2003 | B1 |
| 6656702 | Yugawa et al. | Dec 2003 | B1 |
| 6773564 | Yugawa et al. | Aug 2004 | B1 |
| 7005048 | Watanabe et al. | Feb 2006 | B1 |
| 7049114 | Sode et al. | May 2006 | B1 |
| 7067295 | Sode et al. | Jun 2006 | B1 |
| 7132270 | Kratzsch et al. | Nov 2006 | B2 |
| 7244600 | Sode et al. | Jul 2007 | B2 |
| 7276146 | Wilsey | Oct 2007 | B2 |
| 7514250 | Omura et al. | Apr 2009 | B2 |
| 7553649 | Tsuji et al. | Jun 2009 | B2 |
| 7655130 | Tsuji et al. | Feb 2010 | B2 |
| 7741090 | Sode et al. | Jun 2010 | B2 |
| 8492130 | Yada et al. | Jul 2013 | B2 |
| 8691547 | Omura et al. | Apr 2014 | B2 |
| 8882978 | Yada et al. | Nov 2014 | B2 |
| 8969025 | Takenaka et al. | Mar 2015 | B2 |
| 9328372 | Omura et al. | May 2016 | B2 |
| 9340816 | Yada et al. | May 2016 | B2 |
| 9663811 | Yada et al. | May 2017 | B2 |
| 9957543 | Omura et al. | May 2018 | B2 |
| 9976125 | Yada et al. | May 2018 | B2 |
| 10648011 | Omura et al. | May 2020 | B2 |
| 10669565 | Omura et al. | Jun 2020 | B2 |
| 20030082595 | Jiang et al. | May 2003 | A1 |
| 20030175841 | Watanabe et al. | Sep 2003 | A1 |
| 20040142441 | Weiss | Jul 2004 | A1 |
| 20040266009 | Shuster | Dec 2004 | A1 |
| 20050095619 | Davis et al. | May 2005 | A1 |
| 20060019328 | Sode | Jan 2006 | A1 |
| 20060063217 | Omura et al. | Mar 2006 | A1 |
| 20070105173 | Takeshima et al. | May 2007 | A1 |
| 20080014611 | Kitabayashi et al. | Jan 2008 | A1 |
| 20080014612 | Tsuji et al. | Jan 2008 | A1 |
| 20080206833 | Yamaoka et al. | Aug 2008 | A1 |
| 20080248514 | Inamori et al. | Oct 2008 | A1 |
| 20090181408 | Tanaka et al. | Jul 2009 | A1 |
| 20090259024 | Tsuji et al. | Oct 2009 | A1 |
| 20100135977 | Palczewski et al. | Jun 2010 | A1 |
| 20100323378 | Honda et al. | Dec 2010 | A1 |
| 20110033880 | Yada et al. | Feb 2011 | A1 |
| 20130332133 | Horn | Dec 2013 | A1 |
| 20160076007 | Omura et al. | Mar 2016 | A1 |
| 20160273018 | Omura et al. | Sep 2016 | A1 |
| 20170136102 | Sharma | May 2017 | A1 |
| Number | Date | Country |
|---|---|---|
| 43 01 904 | Feb 1994 | DE |
| 0 094 161 | Nov 1983 | EP |
| 0094161 | Nov 1983 | EP |
| 0 992 589 | Apr 2000 | EP |
| 1 152 239 | Nov 2001 | EP |
| 1 167 519 | Jan 2002 | EP |
| 1 176 202 | Jan 2002 | EP |
| 1 584 675 | Oct 2005 | EP |
| 1 739 174 | Jan 2007 | EP |
| 1 862 543 | Dec 2007 | EP |
| 2 003 199 | Dec 2008 | EP |
| 2 380 980 | Oct 2011 | EP |
| 2 380 980 | Nov 2014 | EP |
| 59-025700 | Feb 1984 | JP |
| 1988-139243 | Jun 1988 | JP |
| 1988-139244 | Jun 1988 | JP |
| 1988-317757 | Dec 1988 | JP |
| 1992-215055 | Aug 1992 | JP |
| 1993-196595 | Aug 1993 | JP |
| 1993-215711 | Aug 1993 | JP |
| 1998-505421 | May 1998 | JP |
| 10-239273 | Sep 1998 | JP |
| 10-243786 | Sep 1998 | JP |
| 2000-262281 | Sep 2000 | JP |
| 2000-312588 | Nov 2000 | JP |
| 2000-350588 | Dec 2000 | JP |
| 2000-354495 | Dec 2000 | JP |
| 2001-037483 | Feb 2001 | JP |
| 2001-046078 | Feb 2001 | JP |
| 2001-197888 | Jul 2001 | JP |
| 2001-346587 | Dec 2001 | JP |
| 2002-223772 | Aug 2002 | JP |
| 2002-526759 | Aug 2002 | JP |
| 2004-512047 | Apr 2004 | JP |
| 2004-173538 | Jun 2004 | JP |
| 2004-313172 | Nov 2004 | JP |
| 2004-313180 | Nov 2004 | JP |
| 2004-329143 | Nov 2004 | JP |
| 2004-344145 | Dec 2004 | JP |
| 2005-089884 | Apr 2005 | JP |
| 2006-091022 | Apr 2006 | JP |
| 2007-289148 | Nov 2007 | JP |
| 2008-154572 | Jul 2008 | JP |
| 2008-178380 | Aug 2008 | JP |
| 2008-206433 | Sep 2008 | JP |
| WO 9820136 | May 1998 | WO |
| WO 0234919 | May 2002 | WO |
| WO 0236779 | May 2002 | WO |
| WO 02072839 | Sep 2002 | WO |
| WO 03012071 | Feb 2003 | WO |
| WO 2004058958 | Jul 2004 | WO |
| WO 2005088288 | Sep 2005 | WO |
| WO 2005103248 | Nov 2005 | WO |
| WO 2006101239 | Sep 2006 | WO |
| WO 2007139013 | Dec 2007 | WO |
| WO 2015060150 | Apr 2015 | WO |
| Entry |
|---|
| Komori et al. (2015) Crystallographic analysis of FAD-dependent glucose dehydrogenase, Struct. Biol. Commun., vol. F71, pp. 1017-1019. |
| Reference “Enzyme Glucose Dehydrogenase FAD Dependent” (2019 updated) p. 1-3. |
| Patent Docs (2019) pp. 1-2. |
| Sckisui Diagnostics (2017) “Enzymes Glucose dehydrogenase Fad dependent” origin Aspergillus sp., pp. 1-3. |
| Bak et al., “Studies on glucose dehydrogenase of Aspergillus oryzae,” Biochimica et Biophysica Acta, 146: 328-335 (1967). |
| Bak, “Studies on Glucose Dehydrogenase of Aspergillus Oryzae III. General Enzymatic Properties,” Biochimica et Biophysica Acta, 146: 317-327 (1967). |
| Bak, “Studies on Glucose Dehydrogenase of Aspergillus Oryzae II, Purification and Physical and Chemical Properties,” Biochimica et Biophysica Acta, 146: 277-293 (1967). |
| Cozier et al., “Characterization of the membrane quinoprotein glucose dehydrogenase from Escherichia coli and characterization of a site-directed mutant in which histidine-262 has been changed to tyrosine,” Biochem. J., 340: 639-647 (1999). |
| European Search Report issued for application No. EP 11156659.2, dated Jun. 28, 2011. |
| European Search Report issued for application No. EP 11156661.8, dated Jun. 6, 2011. |
| European Search Report issued for application No. EP 11156657.6, dated Aug. 25, 2011. |
| European Search Report issued for application No. EP 11156649.3, dated Sep. 23, 2011. |
| European Search Report issued for application No. EP 11156664.2, dated Sep. 23, 2011. |
| Hayano et al., “Purification and Properties of 3-Ketosucrose-forming Enzyme from the Cells of Agrobacterium tumefaciens,” J. of Biol. Chem., 242: 3665-3672 (1967). |
| Kojima et al, “Fundamental study for an oxygen-insensitive amperometric glucose sensor using a novel glucose dehydrogenase,” Chemical Sensors, 20: 768-769 (2004). |
| Morrison et al., “Characterization of a glucose 3-dehydrogenase from the cultivated mushroom (Aqaricus bisporus),” Appl. Microbial Biotechnol, 51: 58-64 (1999). |
| Rolke et al., “Functional analysis of H2O2-generating systems in Botrytis cinerea: the major Cu—Zn-superoxide dismutase (BC50D1) contributes to virulence on French bean, whereas a glucose oxidase (BCG0D1) is dispensable,” Molecular Plant Pathology, 5(1): 17-27 (2004). |
| Tsugawa et al., “Fluorescent measurement of 1,5-anhydro-D-glucitol based on a novel marine bacterial glucose dehydrogenase,” Enzyme and Microbial Technology, 22: 269-274 (1998). |
| Yoshida et al., “Construction of multi-chimeric pyrroloquinoline quinone glucose dehydrogenase with improved enzymatic properties and application in glucose monitoring,” Biotechnology Letters, 22: 1505-1510 (2000). |
| Dickinson et al., “The Reactions of 1,10-Phenanthroline with Yeast Alcohol Dehydrogenase,” Biochem. J., (1977) 167: 237-244. |
| Pire et al., “NAD(P)+-glucose dehydrogenase from Haloferax mediterranei: kinetic mechanism and metal content,” J. Mol. Catalysis B: Enzymatic, 10: 409-417 (2000). |
| Office Action dated Aug. 18, 2011 in U.S. Appl. No. 12/396,724 (11 pages). |
| Response to Office Action filed Dec. 16, 2011 in U.S. Appl. No. 12/396,724 (17 pages). |
| Office Action dated Feb. 14, 2012 in U.S. Appl. No. 12/396,724 (11 pages). |
| Response to Office Action filed May 11, 2012 in U.S. Appl. No. 12/396,724 (19 pages). |
| International Search Report for International Application No. PCT/JP03/16603, dated Mar. 23, 2004 (2 pages). |
| Matsushita et al., “Membrane-bound D-Glucose Dehydrogenase from Pseudomonas sp: Solubilization, Purification and Characterization,” Agric. Biol. Chem., 44(7): 1505-1512 (1980). |
| Ameyama et al., “D-Glucose Dehydrogenase of Gluconobacter suboxydans: Solubilization, Purification and Characterization,” Agric. Biol. Chem., 45(4): 851-861 (1981). |
| Ameyama et al., “Purification of Characterization of the Quinoprotein D-Glucose Dehydrogenase Apoenzyme from Escherichia coli,” Agric. Biol. Chem., 50(1): 49-57 (1986). |
| Dokter et al., “The in vivo and in vitro substrate specificity of quinoprotein glucose dehydrogenase of Acinetobacter calcoaceticus LMD 79.41,” FEMS Microbiology Letters, 43: 195-200 (1987). |
| Igarashi et al., “Construction and Characterization of Mutant Water-Soluble PQQ Glucose Dehydrogenases with Altered Km Values—Site-Directed Mutagenesis Studies on the Putative Active Site,” Biochemical and Biophysical Research Communications, 264: 820-824 (1999). |
| Sode et al., “Improved substrate specificity and dynamic range for glucose measurement of Escherichia coli PQQ glucose dehydrogenase by site directed mutagenesis,” Biotech. Letters, 19(11): 1073-1077 (1997). |
| Supplementary European Search Report, dated Mar. 23, 2006, in EP Application No. EP 03789625.5 (3 pages). |
| Oubrie et al., “Active-site structure of the soluble quinoprotein glucose dehydrogenase complexed with methylhydrazine: A covalent cofactor-inhibitor complex,” Proceedings of the National Academy of Sciences, 96(21):11787-11791 (1999). |
| Kotera et al., “Computational Assignment of the EC Numbers For Genomic-Scale Analysis of Enzymatic Reactions,” J. Am. Chem. Soc., 126: 16487-16498 (2004). |
| Jin et al., “Properties of glucoside 3-dehydrogenase and its potential applications, African J. of Biotechnology,” 7(25): 4843-4849 (2008). |
| Creighton, “Proteins Structures and Molecular Properties,” Second Edition, W.H. Freeman and Company New York, pp. 260-264 (5 pages). |
| ISO 15197: In vitro diagnostic test systems—Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (ISO 15197:2003), International Organization for Standardization, Switzerland 2003 (39 pages). |
| Bennett et al., “Joslin's Diabetes Mellitus Fourteenth Edition,” Chapter 19 “Definition, Diagnosis, and Classification of Diabetes Mellitus and Glucose Homeostasis”; Lippincott Williams & Wilkins, pp. 331-339. |
| Amiel, “Joslin's Diabetes Mellitus Fourteenth Edition,” Chapter 40 “Iatrogenic Hypoglycemia”; Lippincott Williams & Wilkins, pp. 671-686. |
| Ameyama et al., “Existence of a Novel Prosthetic Group, PQQ, in Membrane-Bound, Electron Transport Chain-Linked, Primary Dehydrogenases of Oxidative Bacteria,” FEBS Letters, 130(2): 179-183 (1981). |
| Cass et al., “Ferrocene-Mediated Enzyme Electrode for Amperometric Determination of Glucose,” Am. Chem. Soc., 56(4): 667-671 (1984). |
| Cozier et al., “Structure of the quinoprotein glucose dehydrogenase of Escherichia coli modelled on that of methanol dehydrogenase from Methylobacterium extorquens,” Biochem. J., 312: 679-685 (1995). |
| D'Costa et al., “Quinoprotein Glucose Dehydrogenase and its Application in an Amperometic Glucose Sensor,” Biosensors (1986) 2: 71-87. |
| FDA—“Avoiding Glucose Monitoring Errors in Patients Receiving Other Sugars (Feb. 2006).” Sep. 2006. |
| FDA—“Fatal Iatrogenic Hypoglycemia: Falsely Elevated Blood Glucose Readings with a Point-of-Care Meter Due to a Maltose-Containing Intravenous Immune Globulin Product,” Jun. 18, 2009. |
| FDA—“Parenteral Maltose/Parenteral Galactose/Oral Xylose-Containing Products,” Apr. 22, 2008. |
| FDA—“Important Safety Information on Interference With Blood Glucose Measurement Following Use of Parenteral Maltose/Parenteral Galactose/Oral Xylose-Containing Products,” May 21, 2009. |
| “HY-RiSE® Colour Hygiene Test Strip”. |
| “Hemocue® Blood Glucose Analyzer Operating Manual”. |
| Lau et al., “Improved specificity of reagentless amperometric PQQ-sGDH glucose biosensors by using indirectly heated electrodes,” Biosensors and Bioelectronics, 22: 3014-3020 (2007). |
| Laurinavi{hacek over (c)}ius et al., “A Novel Application of Heterocyclic Compounds for Biosensors Based on NAD, FAD, and PQQ Dependent Oxidoreductases,” Monatshefte für Chemie, 130: 1269-1281 (1999). |
| Turner, “Biosensors for process monitoring & control,” The World Biotech Report, 1: 181-192 (1985). |
| Wens et al., “A Previously Undescribed Side Effect of Icodextrin: Overestimation of Glycemia by Glucose Analyzer,” Peritoneal Dialysis International, 18: 603-609 (1998). |
| Yoo et al., “Glucose Biosensors: An Overview of Use in Clinical Practice,” Sensors, 10: 4558-4576 (2010). |
| Accession No. Q2USF2, filed in Opposition Proceeding Against EP 2 380 980 (3 pages). |
| Acuña-Argüelles et al., “Production and properties of three pectinolytic activities produced by Aspergillus niger in submerged and solid-state fermentation,” Applied Microbiology and Biotechnology, 43: 808-814 (1995). |
| Alignment between FAD-linked Glucose Dehydrogenase from Aspergillus terreus (SEQ ID No. 1 from EP2380980 B1) and contig 206 from Aspergillus terreus (cont1.206; GenBank accession AAJN01000206.1), submitted to the European Patent Office on Aug. 4, 2015. |
| Alignment between choline dehydrogenase (GenBank Protein ID BAE55513.1) from Aspergillus oryzae and translated contig 206 from Aspergillus terreus (nt 55816-57706 cont1.206; GenBank accession AAJNO1000206.1), submitted to the European Patent Office on Aug. 4, 2015. |
| Alignment between Glucose Oxidase (GenBank Protein ID EAL93778.1) from Aspergillus fumigatus and translated contig 206 from Aspergillus terreus (nt 55816-57709 cont1.206; GenBank accession AAJNO1000206.1), submitted to the European Patent Office on Aug. 4, 2015. |
| Alignment between the A. fumigatus glucose oxidase and the sequence of SEQ ID No. 2, dated Jul. 27, 2015. |
| Alignment between the A. oryzae choline dehydrogenase and the sequence of SEQ ID No. 2, dated Jul. 27, 2015. |
| Alignment between the mutant GLD of A. oryzae and the sequence of SEQ ID No. 2, dated Jul. 31, 2015. |
| Alignment between the wildtype GLD of A. oryzae and the sequence of SEQ ID No. 2, dated Jul. 31, 2015. |
| Alignment BLAST of the protein sequence of glucose dehydrogenase of SEQ ID No. 1 and AAJNO1000206.1 of Aspergillus terreus NIH2624, GenBank Accession AAJNO1000206.1, dated Aug. 4, 2015. |
| Alignment of sequences of SEQ ID No. 2 and the choline dehydrogenase of A. oryzae and the glucose oxidase of A. fumigatus, submitted to the European Patent Office on Aug. 4, 2015. |
| Alignment of the protein sequence of glucose dehydrogenase of SEQ ID No. 2 and XM_001216916, dated Jun. 11, 2015. |
| Alignment of the protein sequence of glucose dehydrogenase SEQ ID No. 2 and European Nucleotide Archive Entry AP007151, dated Dec. 21, 2005. |
| Amendment after Final filed Mar. 13, 2013, in U.S. Appl. No. 12/866,071 (7 pages). |
| Amendment and Reply to Final Office Action under 37 C.F.R. § 1.116 filed Apr. 12, 2013 in U.S. Appl. No. 11/886,885 (12 pages). |
| Amendment and Reply to Restriction Requirement filed Jul. 6, 2012 in U.S. Appl. No. 11/886,885 (16 pages). |
| Amendment and Response to Restriction Requirement filed Aug. 27, 2012, in U.S. Appl. No. 12/866,071 (7 pages). |
| Amendment filed Dec. 26, 2012, in U.S. Appl. No. 12/866,071 (15 pages). |
| Ashcroft, Ion Channels and Disease, Academic Press, San Diego, CA, pp. 54-55 (1999). |
| Bak et al., “Studies on the Glucose Dehydrogenase of Aspergillus Oryzae. I. Induction of its synthesis by p-benzoquinone and hydroquinone,” Biochim. Biophys. Acta, 139: 265-276 (1967) (7 pages). |
| BIOspektrum, 10. Jahrgang, Neu auf dem Markt, GlycoProfile—neue Kits für Glycoprotein-Analysen (pp. 218-221) (4 pages). |
| Cavener, “GMC Oxidoreductases: A Newly Defined Family of Homologous Proteins with Diverse Catalytic Activities,” J. Mol. Biol., 223: 811-814 (1992). |
| Cavener, D. et al., “Biphasic expression and function of glucose dehydrogenase in Drosophila melanogaster,” Proc. Natl. Acad. Sci., 80: 6286-6288 (1983). |
| Chica et al., “Semi-rational approaches to engineering enzyme activity: combining the benefits of directed evolution and rational design,” Current Opinion in Biotechnology, 16: 378-384 (2005). |
| Communication pursuant to Rule 114(2) EPC dated Aug. 26, 2010 by the European Patent Office in connection with European Patent Application No. 06730146.5 (7 pages). |
| CV of Takahide Kishimoto, submitted to the European Patent Office on Aug. 4, 2015. |
| De Baetselier et al., “Fermentation of a Yeast Producing A. Niger Glucose Oxidase: Scale-Up, Purification and Characterization of the Recombinant Enzyme,” Nature Biotechnology, 9: 559-561 (1991). |
| DEAE Cellulofine Ion Exchange Chromatography, Seikagaku Corp. (Mar. 10, 1988) (pp. 1-14) (29 pages in total, including translation). |
| Declaration of Dr. Kitabayashi, Oct. 7, 2016 (pp. 1-4) (4 pages). |
| Declaration of Mr. Kawai, Oct. 7, 2016 (5 pages). |
| Response to Office Action filed Oct. 25, 2017 in U.S. Appl. No. 15/079,002 (3 pages). |
| Notice of Allowance for U.S. Appl. No. 15/079,002, dated Dec. 22, 2017, (8 pages). |
| Declaration of Mr. Kishimoto, Oct. 8, 2016 (10 pages). |
| Declaration of Prof. Becker, Oct. 4, 2016 (pp. 1-2) (2 pages). |
| Declaration of Prof. Nishiya, Oct. 6, 2016 (pp. 1-11) (11 pages). |
| Edge, “Deglycosylation of Glycoproteins by Trifluoromethanesulphonic Acid,” Analytical Biochem., 118: 131-137 (1981). |
| Edge, “Deglycosylation of glycoproteins with trifluoromethanesulphonic acid: elucidation of molecular structure and function,” Biochem. J., 376: 339-350 (2003). |
| Edman, “A method for the determination of amino acid sequence in peptides,” Archives of Biochemistry, 22: 475-476 (1949). |
| European Nucleotide Archive entry AAHF01000001: genome sequence of A. Fumigatus, issued Jun. 2, 2005. |
| European Nucleotide Archive Entry AP007151: A. oryzae genomic DNA, issued Dec. 21, 2005. |
| European Patent Office correspondence related to Application No. EP 2 380 980 (EP 11 15 6649.3), dated Oct. 10, 2016, from Dr. Jurgen Meier, European Patent Attorney (pp. 1-58) (58 pages). |
| European Patent Office correspondence related to Application No. EP 2 380 980 (EP 11 15 6649.3), dated Oct. 10, 2016, from Dr. Raphael Bösl, European Patent Attorney (pp. 1-9) (9 pages). |
| Experiment Report dated Mar. 1, 2015. |
| Ferri et al., “Review of glucose oxidases and glucose dehydrogenases: A bird's eye view of glucose sensing enzymes,” Journal of Diabetes Science and Technology, 5(5): 1068-1076 (2011). |
| Final Office Action dated Feb. 13, 2013 in U.S. Appl. No. 11/886,885, (12 pages). |
| Final Office Action dated Jan. 31, 2013, in U.S. Appl. No. 12/866,071, (5 pages). |
| Frederick et al., “Glucose oxidase from Aspergillus niger. Cloning, gene sequence, secretion from Saccharomyces cerevisiae and kinetic analysis of a yeast-derived enzyme,” J. Biol. Chem., 265(7): 3793-3802 (1990). |
| Frylingou et al., “Aspergillus oryzae FAD-GDH (wt): TFMS deglycosylation and peptide mapping,” dated Aug. 3, 2015 (7 pages). |
| Galagan et al., “Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae,” Nature, 438: 1105-1115 (2005). |
| Gomi et al., “Cloning and Nucleotide Sequence of the Acid Protease-encoding Gene (pepA) from Aspergillus oryzae,” Biosci. Biotech. Biochem., 57 (7), 1095-1100 (1993). |
| Harayama et al., “Biochemical characterization of sialoprotein “anti-agglutinin” purified from boar epididymal and seminal plasma,” Molecular Reproduction and Development, 55: 96-103 (2000). |
| Harper's Review of Biochemistry, 20th ed., by Martin et al., 1985, p. 503 (19 pages). |
| Hata, “Gene expression in solid-state culture of Aspergillus oryzae,” Journal of the Agricultural Chemical Society of Japan, 76(8): 715-718 (2002). |
| Hatzinikolaou et al., “A new glucose oxidase from Aspergillus niger: characterization and regulation studies of enzyme and gene,” Appl Microbiol. Biotechnol., 46: 371-381 (1996). |
| Yurimoto et al., “Heterologous gene expression system by methanol-utilizing yeast,” Chemistry & Biology, 38(8): 533-540 (2000). |
| Inose et al., “Cloning and expression of the gene encoding catalytic subunit of thermostable glucose dehydrogenase from Burkholderia cepacia in Escherichia coli,” Biochimica et Biophysica Acta, 1645:133-138 (2003). |
| International Search Report issued for International Application No. PCT/JP2006/306198, dated Apr. 25, 2006. |
| Isao Ishida and Tamie Ando (ed.), “Laboratory Manual for Gene Expression, Production of useful protein in high expression system,” Kodansha Scientific Ltd., pp. 100-129 (1994). |
| Iwashita et al., “Purification and Characterization of Extracellular and Cell Wall Bound beta-Glucosidases from Aspergillus kawachii,” Biosci. Biotechnol. Biochem., 62(10): 1938-1946 (1998). |
| Jarai et al., “Cloning and characterization of the pepD gene of Aspergillus niger which codes for a subtilisin-like protease,” Gene, 139: 51-57 (1994). |
| Jenkins et al., “Glycosylation of recombinant proteins: problems and prospects,” Enzyme Microb. Technol., 16: 354-364 (1994). |
| Kainz, Elke et al., “N-Glycan Modification in Aspergillus Species,” Applied and Environmental Microbiology, 74(4): 1076-1086 (2008). |
| Kataoka et al., “Escherichia coli transformant expressing the glucose dehydrogenase gene from Bacillus megaterium as a cofactor regenerator in a chiral alcohol production system,” Biosci Biotechnol Biochem (1998), 62(1): 167-169. |
| Kiso et al., “2.1 Dye Binding Method (Bradford method, CBB method),” Basic Biochemistry Experimentation Method, Minako Ozawa, Tokyo Kagaku Dojin Co., Ltd., pp. 3-25, 142-149, and 160-161 (2001). |
| Kojima et al., “Shinki Glucose Dehydrogenase o Mochiita Sanso Fukan' no-sei Ketto Sensor no Kiso Kento (1),” The Japan Society for Analytical Chemistry Nenkai Koen Yoshishu, 53: 80 (2004). |
| Kriechbaum et al., “Cloning and DNA sequence analysis of the glucose oxidase gene from Aspergillus niger NRRL-3,” FEBS, 255: 63-66 (1989). |
| Lorenzo et al., “O-glycans as a source of cross-reactivity in determinations of human serum antibodies to Anisakis simplex antigens,” Clinical and Experimental Allergy, 30: 551-559 (2000). |
| Machida et al., “Genome sequencing and analysis of Aspergillus oryzae,” Nature, 438: 1157-1161 (2005). |
| Machida, “EST Analysis of Aspergillus oryzae,” Chemistry and Organism, 39: 384-388 (2001). |
| Maley et al., “Characterization of Glycoproteins and Their Associated Oligosaccharides through the Use of Endoglycosidases,” Analytical Biochemistry, 180: 195-204 (1989). |
| Meier, “Amino acid composition and N-terminal sequencing of Aspergillus oryzae FAD-GDH,” submitted to the European Patent Office on Aug. 5, 2015. |
| Nakayama, “Cell Engineering, separate volume, Visible Experiment Notebook Series, I Illustrated Biological Experiment /No. 3 PCR for reliable amplification,” Chihiro Mizutani, Shujunsha Co., Ltd. (1996). |
| NCBI entry AAJN00000000.1: genome sequence of Aspergillus terreus, dated Jul. 31, 2015. |
| NCBI entry XM_001216916: Aspergillus terreus NIH2624 hypothetical protein (ATEG_08295), dated Mar. 31, 2008. |
| NCMI entry XP_002372599: sequence of the glucose oxidase of A. flavus, submitted Jun. 16, 2005. |
| New Biochemical Experiment Course 1 Protein II “Primary Structure”, Tokyo Kagaku Dojin, Dec. 1, 1993, 1st edition, 2nd printing, pp. 1-24. |
| New England BioLabs, Inc., Mar. 2002 Catalog & Technical Reference, pp. 176-177. |
| News of the BROAD institute of Sep. 30, 2005 regarding the Aspergillus terreus assembly release. |
| Nielsen et al, “Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites,” Protein Engineering, 10(1): 1-6 (1997). |
| Nierman et al., “Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus,” Nature, 438: 1151-1156 (2005). |
| Notice of Allowance for U.S. Appl. No. 11/886,885, dated Nov. 21, 2013, (17 pages). |
| Notice of Allowance for U.S. Appl. No. 12/866,071, dated Mar. 25, 2013, (6 pages). |
| Notice of Allowance for U.S. Appl. No. 13/920,445, dated Apr. 7, 2014, Examiner Christian Fronda (12 pages). |
| Notice of Allowance for U.S. Appl. No. 13/920,445, dated Jul. 10, 2014, (8 pages). |
| Notice of Allowance for U.S. Appl. No. 14/184,573, dated Aug. 28, 2015, (10 pages). |
| Notice of Allowance for U.S. Appl. No. 14/184,573, dated Dec. 23, 2015, (10 pages). |
| Notice of Allowance for U.S. Appl. No. 14/510,076, dated Sep. 2, 2015, (5 pages). |
| Notice of Allowance for U.S. Appl. No. 14/510,076, dated Jan. 21, 2016, (7 pages). |
| Notice of Allowance dated Jan. 23, 2017, in U.S. Appl. No. 15/135,375, (7 pages). |
| Notice of opposition to a European Patent for EP Patent No. 2380980, dated Aug. 5, 2015, filed by Roche Diabetes Care GmbH (pp. 1-18). |
| Notice of opposition to a European Patent for EP Patent No. 2380980, dated Aug. 4, 2015, filed by Toyobo, Co., Ltd. (pp. 1-45). |
| Notice of Submission of Published Documents dated Feb. 10, 2009 for counterpart Japanese Patent Application No. 2007-509374. |
| Notification of Reasons for Refusal dated Aug. 9, 2016, in Patent Application No. 2015-154989. |
| Office Action dated Aug. 2, 2011 in connection with Japanese Patent Application No. JP 2007-509374. |
| Office Action dated Apr. 9, 2012 in U.S. Appl. No. 11/886,885, (8 pages). |
| Office Action dated Aug. 9, 2016, in U.S. Appl. No. 15/135,375, (15 pages). |
| Office Action dated Jul. 25, 2012, in U.S. Appl. No. 12/866,071, (5 pages). |
| Office Action dated Jul. 26, 2017 in U.S. Appl. No. 15/496,935 (8 pages). |
| Office Action dated Nov. 15, 2017 in U.S. Appl. No. 15/496,935 (4 pages). |
| Office Action dated Sep. 13, 2012 in U.S. Appl. No. 11/886,885, (16 pages). |
| Office Action dated Sep. 25, 2012, in U.S. Appl. No. 12/866,071, (11 pages). |
| Okumura et al., “A novel phosolipase A2 inhibitor with leucine-rich repeats from the blood plasma of Agkistrodon blomhoffii siniticus,” J. Biol. Chem., 273: 19469-19475 (1998). |
| Okumura et al., “Consideration regarding reaction characteristics of FAD-dependent glucose dehydrogenase with mediator,” Review of Polarography, 51(3): 193 (2005) (5 pages). |
| Package insert of “N-Glycosidase F, recombinant, Peptide-N-glycosidase F, PNGase, F, peptide-N4-(acetyl-β-glucosaminyl) asparagine amidase cloned from Flavobacterium meningosepticum and expressed in E. coli,” EC 3.2.218; 3.5.1.52, (Roche), Version 3, May 2003 (2 pages). |
| Pandey et al., “Solid state fermentation for production of industrial enzymes,” Current Science, 77: 149-162 (1999). |
| Pharmaceutical and Food Safety Bureau Issue No. 0207005, Feb. 7, 2005; “Safety Measures of Simple Instrument for Self-Checking Blood Glucose and Glucose Kit for Self-Testing Blood Glucose (Using Pyrrolo-Quinoline Quinone as Coenzyme in Glucose Dehydrogenase Method).”. |
| PRNewswire of Mar. 4, 2004, Sigma Introduces GlycoProfile™ Kits for Glycoprotein Analysis (pp. 1-4) (4 pages). |
| Ramesh et al., “Cloning and characterization of the cDNAs and genes (mep20) encoding homologous metalloproteinases from Aspergillus flavus and A. fumigatus,” Gene, 165: 121-125 (1995). |
| Response to Office Action filed Dec. 9, 2016, in U.S. Appl. No. 15/135,375 (9 pages). |
| Response to Office Action filed Oct. 25, 2017 in U.S. Appl. No. 15/496,935 (5 pages). |
| Reply to Office Action under 37 C.F.R. § 1.111 filed Dec. 11, 2012 in U.S. Appl. No. 11/886,885 (18 pages). |
| Revision History of NCBI entry AAJN00000000.1, dated Jul. 29, 2015. |
| Roche Applied Science, Instruments and Biochemicals, 2005 Catalog, pp. 530-541 (2005). |
| Romanos et al., “Foreign gene expression in yeast: a review,” Yeast, 8: 423-488 (1992). |
| Sandhya et al., “Comparative evaluation of neutral protease production by Aspergillus oryzae in submerged and solid-state fermentation,” Process Biochemistry, 40: 2689-2694 (2005). |
| Sangadala et al., “Subunit structure of deglycosylated human and swine trachea and Cowper's gland mucin glycoproteins,” Molecular and Cellular Biochemistry, 102: 71-93 (1991). |
| Sen et al., “Developments in Directed Evolution for Improving Enzyme Functions,” Applied Biochemistry and Biotechnology, 143(3): 212-223 (2007). |
| Sigma-Aldrich Press Release, Kits for Glycoprotein Analysis (Mar. 2, 2004) (pp. 1-3) (3 pages), available at http://laboratorytalk.com/article/53744/kits-for-glycoprotein-analysis. |
| Sode et al., “A novel thermostable glucose dehydrogenase varying temperature properties by altering its quarternary structures,” Enzyme and Microbial Technology, 19: 82-85 (1996). |
| Sojar, Hakimuddin T. et al., “Chemical Deglycosylation of Glycoproteins,” Methods in Enzymology, 138: 341-350 (1987). |
| Spiro, “Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds,” Glycobiology, 12(4): 43R-56R (2002). |
| Stanbury et al., “Principles of Fermentation Technology,” Pergamon Press Ltd. 1987 (pp. 3-5, 86-87, 108, 112-115, 145, 196-198, 213-215). |
| Sumantha et al., “Microbiology and Industrial Biotechnology of Food-Grade Proteases: A Perspective,” Food Technol. Biotechnol., 44(2): 211-220 (2006). |
| Summary of the Annual Meeting of Japan Society for Bioscience 2004, Biotechnology and Agrochemistry, , 96: 2A25p11 (Mar. 5, 2004) (3 pages). |
| Tsugawa et al., “Purification of a Marine Bacterial Glucose Dehydrogenase from Cytophaga marinoflava and its Application for Measurement of 1,5-Anhydro-D-Glucitol,” Applied Biochemistry and Biotechnology, 56: 301-310 (1996). |
| Tsujimura et al., “Novel FAD-Dependent Glucose Dehydrogenase for a Dioxygen-Insensitive Glucose Biosensor,” Biosci. Biotechnol. Biochem., 70(3): 654-659 (2006). |
| Tsujimura et al., “Absolute quantification of glucose by coulometry using novel glucose dehydrogenase,” Abstract of the 72nd Meeting of the Electrochemical Society of Japan, 2D04 (2005). |
| Tsujita et al., “Chemical Properties of the Polysaccharides Associated with Acid Protease of Aspergillus oryzae Grown on Solid Bran Media,” J. Biochem., 81: 1063-1070 (1977). |
| Tsujita et al., “Purification and Characterization of the Two Molecular Forms of Aspergillus oryzae acid protease,” Biochimica et Biophysica Acta, 445: 194-204 (1976). |
| Tsujita et al., “Purification and Characterization of the Two Molecular Forms of Membrane Acid Protease from Aspergillus oryzae,” European Journal of Biochemistry, 84: 347-353 (1978). |
| Tsujita et al., “Extracellular Acid Protease of Aspergillus oryzae Grown on Liquid Media: Multiple Forms due to Association with Heterogeneous Polysaccharides,” J. Bacteriol., 130: 48-56 (1977). |
| Volc et al., “Pyranose 2-dehydrogenase, a novel sugar oxidoreductase from the basidiomycete fungus Agricus bisporus,” Arch Microbial, 167: 119-125 (1997). |
| Volc et al., “Screening of basidiomycete fungi for the quinone-dependent sugar C-2/C-3 oxidoreductase, pyranose dehydrogenase, and properties of the enzyme from Macrolepiota rhacodes,” Arch Microbial 176: 178-186 (2001). |
| Whittington et al., “Expression of the Aspergillus niger glucose oxidase gene in A. niger, A. nidulans and Saccharomyces cerevisiae,” Current Genetics, 18: 531-536 (1990). |
| Witt et al., “Structural and Kinetic Properties of Nonglycosylated Recombinant Penicillium amagasakiense Glucose Oxidase Expressed in Escherichia coli,” Applied and Environmental Microbiology, 64: 1405-1411 (1998). |
| Yamada et al., “dffA Gene from Aspergillus oryzae encodes L-ornithine N5-oxygenase and is indispensable for deferriferrichrysin biosynthesis,” Journal of Bioscience and Bioengineering, 95(1): 82-88 (2003). |
| Yamada et al., “Transformation System for Aspergillus oryzae with Double Auxotrophic Mutations, niaD and sC,” Biosci. Biotech. Biochem., 61(8): 1367-1369 (1997). |
| Yang et al., “Efficient expression, purification, and characterization of a novel FAD-dependent glucose dehydrogenase from Aspergillus terreus in Pichia pastoris,” J. Microbiol. Biotechnol., 24(11): 1516-1524 (2014). |
| Yang et al., “Expression, characterization and mutagenesis of an FAD-dependent glucose dehydrogenase from Aspergillus terreus,” Enzyme and Microbial Technology, 68: 43-49 (2015). |
| Yoshino et al., “Cloning and expression of catalytic subunit of glucose dehydrogenase from Burkholderia cepacia,” Society for Biotechnology, Japan (Oct. 28-30, 2002). |
| Zámocký et al., “Ancestral gene fusion in cellobiose dehydrogenases reflects a specific evolution of GMC oxidoreductases in fungi,” Gene, 338:1-14 (2004). |
| Office Action dated Nov. 4, 2016 in U.S. Appl. No. 14/951,457, (8 pages). |
| Office Action dated Aug. 2, 2017 in U.S. Appl. No. 15/079,002, (10 pages). |
| Office Action dated Dec. 10, 2007 in U.S. Appl. No. 10/540,025 (5 pages). |
| Response to Office Action filed Feb. 8, 2008 in U.S. Appl. No. 10/540,025 (1 page). |
| Office Action dated May 22, 2008 in U.S. Appl. No. 10/540,025 (17 pages). |
| Response to Office Action filed Aug. 22, 2008 in U.S. Appl. No. 10/540,025 (12 pages). |
| Notice of Allowance dated Dec. 15, 2008 in U.S. Appl. No. 10/540,025 (8 pages). |
| Matsumoto et al., “Development of a micro-planar Ag/AgCl quasi-reference electrode with long-term stability for an amperometric glucose sensor,” Analytic. Chimica Acta, 462: 253-259 (2002). |
| Office Action dated Feb. 14, 2013 in U.S. Appl. No. 12/396,724 (13 pages). |
| Response to Office Action filed Jan. 10, 2014 in U.S. Appl. No. 12/396,724 (9 pages). |
| Office Action dated Feb. 27, 2014 in U.S. Appl. No. 12/396,724 (12 pages). |
| Office Action dated Feb. 14, 2012 in U.S. Appl. No. 12/851,668 (7 pages). |
| Response to Office Action filed May 11, 2012 in U.S. Appl. No. 12/851,668 (10 pages). |
| Office Action dated Jul. 11, 2012 in U.S. Appl. No. 12/851,668 (9 pages). |
| Response to Office Action filed Oct. 5, 2012 in U.S. Appl. No. 12/851,668 (10 pages). |
| Advisory Action dated Oct. 16, 2012 in U.S. Appl. No. 12/851,668 (3 pages). |
| Response to Office Action filed May 28, 2013 in U.S. Appl. No. 12/851,668 (11 pages). |
| Office Action dated Jul. 2, 2013 in U.S. Appl. No. 12/851,668 (12 pages). |
| Declaration of A. Turner filed Dec. 27, 2013 in U.S. Appl. No. 12/851,668, with exhibits (175 pages). |
| Response to Office Action filed Dec. 27, 2013 in U.S. Appl. No. 12/851,668 (17 pages). |
| Advisory Action dated Jan. 10, 2014 in U.S. Appl. No. 12/851,668 (4 pages). |
| Appeal Brief filed Jul. 11, 2014 in U.S. Appl. No. 12/851,668 (40 pages). |
| Examiner's Answer dated Oct. 2, 2014 in U.S. Appl. No. 12/851,668 (24 pages). |
| Reply Brief filed Dec. 1, 2014 in U.S. Appl. No. 12/851,668 (31 pages). |
| Decision on Appeal mailed Jul. 28, 2017 in U.S. Appl. No. 12/851,668 (17 pages). |
| Opening Brief filed Feb. 7, 2018 in U.S. Appl. No. 12/851,668, before Court of Appeals for the Federal Circuit (86 pages). |
| Response Brief filed Apr. 18, 2018 in U.S. Appl. No. 12/851,668, before Court of Appeals for the Federal Circuit (42 pages). |
| Reply Brief filed Jun. 1, 2018 in U.S. Appl. No. 12/851,668, before Court of Appeals for the Federal Circuit (32 pages). |
| Advisory Action dated May 8, 2013 in U.S. Appl. No. 11/886,885 (3 pages). |
| Response to Office Action filed Feb. 2, 2017 in U.S. Appl. No. 14/951,457 (6 pages). |
| Office Action dated Mar. 23, 2017 in U.S. Appl. No. 14/951,457 (13 pages). |
| Office Action dated Mar. 1, 2017 in U.S. Appl. No. 15/079,002 (6 pages). |
| Response to Office Action filed May 16, 2017 in U.S. Appl. No. 15/079,002 (4 pages). |
| Response to Office Action filed Jul. 7, 2017 in U.S. Appl. No. 15/496,935 (3 pages). |
| Response to Office Action filed Dec. 22, 2017 in U.S. Appl. No. 15/496,935 (4 pages). |
| Notice of Allowance dated Jan. 19, 2018 in U.S. Appl. No. 15/496,935 (7 pages). |
| International Search Report for International Application No. PCT/JP00/02322, dated May 16, 2000 (2 pages). |
| International Search Report for International Application No. PCT/EP01/12148, dated Mar. 25, 2002 (3 pages). |
| International Search Report issued for International Application No. PCT/JP00/02872, dated Aug. 8, 2000 (1 page). |
| Notice of Appeal filed Aug. 26, 2014 in U.S. Appl. No. 12/396,724 (2 pages). |
| Notice of Appeal Filed Sep. 26, 2017, in U.S. Appl. No. 12/851,668, before the Court of Appeals for the Federal Circuit (20 pages). |
| Zhang et al., “Purification and characterization of the glucoside 3-dehydrogenase produced by a newly isolated Stenotrophomonas maltrophilia CCTCC M 204024,” Appl. Microbio. Biotech., 71: 638-645 (2006). |
| Office Action dated Mar. 23, 2017 in U.S. Appl. No. 14/951,457 (14 pages). |
| Office Action dated May 10, 2017 in U.S. Appl. No. 15/496,935 (6 pages). |
| Notice of Appeal filed Dec. 10, 2012 in U.S. Appl. No. 12/851,668 (2 pages). |
| Interview Summary dated Jun. 28, 2013 in U.S. Appl. No. 12/851,668 (4 pages). |
| Notice of Appeal filed Dec. 31, 2013 in U.S. Appl. No. 12/851,668 (1 page). |
| Kishimoto, Experiment Report, filed in Opposition Proceeding Against EP 2 380 980, dated Mar. 1, 2015 (1 page). |
| GENETYX: Amino Acid Sequence Homology Data Comparing A. oryzae Wild Type Sequence, filed in Opposition Proceeding Against EP 2 380 980, dated Jul. 31, 2015 (1 page). |
| GENETYX: Amino Acid Sequence Homology Data Comparing A. oryzae Mutant Sequence, filed in Opposition Proceeding Against EP 2 380 980, dated Jul. 31, 2015 (1 page). |
| CV of T. Kishimoto, filed in Opposition Proceeding Against EP 2 380 980 (2 pages). |
| Declaration of K. Gomi, filed in Opposition Proceeding Against EP 2 380 980, dated Mar. 10, 2016 (5 pages). |
| Declaration of T. Yada, filed in Opposition Proceeding Against EP 2 380 980, dated Mar. 18, 2016 (9 pages). |
| UniProtKB Results, filed in Opposition Proceeding Against EP 2 380 980, dated Feb. 24, 2016 (5 pages). |
| Annex: Sequence Comparison of Different FAD-linked Glucose Dehydrogenases (GLDs), filed in Opposition Proceeding Against EP 2 380 980, dated Mar. 11, 2016 (20 pages). |
| Annex: Comparison of GLDs (Parallel Editor by GENETYX), filed in Opposition Proceeding Against EP 2 380 980 (3 pages). |
| Annex: Sequence Alignment of SEQ ID No. 2 with PQQ Glucose Dehydrogenase, filed in Opposition Proceeding Against EP 2 380 980, dated Mar. 15, 2016 (3 pages). |
| Submission to the European Patent Office Concerning Name Change of Toyobo Co., Ltd., filed in Opposition Proceeding Against EP 2 380 980, dated Oct. 23, 2012 (15 pages). |
| Translation of Submission to the Japan Patent Office, filed in Opposition Proceeding Against EP 2 380 980 (14 pages). |
| Declaration of M. Ohta, filed in Opposition Proceeding Against EP 2 380 980, dated Mar. 1, 2016 (5 pages). |
| BLAST and “GeneDoc” Sequence Comparison of A. terreus and B. cepacia GLD, filed in Opposition Proceeding Against EP 2 380 980 (3 pages). |
| Submission to the European Patent Office Concerning EP Application No. 07739741.2, filed in Opposition Proceeding Against EP 2 380 980, dated Feb. 23, 2010 (2 pages). |
| Examination Report Concerning EP Application No. 07 739 741.2-2406, filed in Opposition Proceeding Against EP 2 380 980, dated Oct. 16, 2009 (3 pages). |
| Shotgun Assembly Sequences: Genome (WGS) and Transcriptome (TSA); AAJN00000000.1 A. terreus NIH2624, filed in Opposition Proceeding Against EP 2 380 980, dated Feb. 14, 2016 (5 pages). |
| Submission to the European Patent Office Concerning EP Patent Application No. 07739741.2, filed in Opposition Proceeding Against EP 2 380 980, dated Oct. 14, 2010 (3 pages). |
| General Information for Authors of Food Technology and Biotechnology, filed in Opposition Proceeding Against EP 2 380 980 (1 page). |
| CV of A. Kawai, filed in Opposition Proceeding Against EP 2 380 980 (1 page). |
| CV of T. Kishimoto, filed in Opposition Proceeding Against EP 2 380 980 (1 page). |
| CV of Y. Nishiya, filed in Opposition Proceeding Against EP 2 380 980 (2 pages). |
| CV of M. Kitabayashi, filed in Opposition Proceeding Against EP 2 380 980 (1 page). |
| BLAST® (Basic Local Alignment Search Tool), filed in Opposition Proceeding Against EP 2 380 980, dated May 23, 2017 (4 pages). |
| FASTA Sequence Comparison at the University of Virginia, filed in Opposition Proceeding Against EP 2 380 980, dated May 23, 2017 (1 page). |
| Notice of Furnishing for Accession No. FERM BP-08578, filed in Opposition Proceeding Against EP 2 380 980, dated May 18, 2016 (1 page). |
| Declaration of T. Yada, filed in Opposition Proceeding Against EP 2 380 980, dated Jun. 27, 2017 (12 pages). |
| Declaration of K. Gomi, filed in Opposition Proceeding Against EP 2 380 980, dated Sep. 25, 2017 (6 pages). |
| Declaration of M. Ohta, filed in Opposition Proceeding Against EP 2 380 980, dated Sep. 22, 2017 (4 pages). |
| Comparison of Sample from EP 2 380 980, filed in Opposition Proceeding Against EP 2 380 980, dated Sep. 29, 2017 (1 page). |
| Hata et al., “Comparison of Two Glucoamylases Produced by Aspergillus oryzae in Solid-State Culture (Koji) and in Submerged Culture,” J. Fermentation & Bioeng., 84(6): 532-537 (1997). |
| Ishida et al., Isolation of a Novel Promoter for Efficient Protein Production in Aspergillus oryzae, Bioscience Biotechnology Biochemistry, 68(9): 1849-1857 (2004). |
| Revision History of Accession No. XP_002372599.1, filed in Opposition Proceeding Against EP 2 380 980, dated Sep. 29, 2017 (1 page). |
| Annex: Sequence Comparison of Different FAD-linked Glucose Dehydrogenases (GLDs) (Updated), filed in Opposition Proceeding Against EP 2 380 980 (27 pages). |
| GENETYX: Homology Data, filed in Opposition Proceeding Against EP 2 380 980, dated May 17, 2017 (1 page). |
| Markel et al., “Sequence Analysis in a Nutshell: A Guide to Common Tools and Databases,” O'Reilly & Associates, Inc., pp. 158-159 (2003). |
| Emboss Pairwise Alignment Algorithms, filed in Opposition Proceeding Against EP 2 380 980, dated Mar. 17, 2005 (1 of 2) (1 page). |
| Emboss Pairwise Alignment Algorithms, filed in Opposition Proceeding Against EP 2 380 980, dated Mar. 17, 2005 (2 of 2) (1 page). |
| Shin Nihon Chemical Co., Ltd., Sumizyme PX Umizyme, filed in Opposition Proceeding Against EP 2 380 980 (2 pages). |
| Shin Nihon Chemical Co., Ltd., Sumizyme ARS Umizyme, filed in Opposition Proceeding Against EP 2 380 980 (2 pages). |
| Declaration of M. Ohta, filed in Opposition Proceeding Against EP 2 380 980, dated Oct. 12, 2018 (3 pages). |
| Declaration of G. Pasut, filed in Opposition Proceeding Against EP 2 380 980, dated Oct. 16, 2018 (12 pages). |
| Glick, Methods of Biochemical Analysis vol. III, pp. v-vii, 111-152. |
| Thermo Scientific, Instructions for GlycoLink™ Coupling Catalyst, filed in Opposition Proceeding Against EP 2 380 980 (4 pages). |
| Sigma, Sodium Borohydride Product Information, filed in Opposition Proceeding Against EP 2 380 980 (1 page) (D120c). |
| European Patent Office Opposition Decision, filed in Opposition Proceeding Against EP 2 380 980, dated Jan. 25, 2018 (37 pages). |
| European Patent Office Summary of Proceedings and Submitted Evidence, filed in Opposition Proceeding Against EP 2 380 980, dated Feb. 16, 2017 (19 pages). |
| Response by Ikeda Food Research Co., Ltd., filed in Opposition Proceeding Against EP 2 380 980, dated Oct. 17, 2018 (90 pages). |
| Response by Ikeda Food Research Co., Ltd., filed in Opposition Proceeding Against EP 2 380 980, dated Mar. 21, 2016 (84 pages). |
| Response by Ikeda Food Research Co., Ltd., filed in Opposition Proceeding Against EP 2 380 980, dated Sep. 29, 2017 (44 pages). |
| Grounds of Appeal by Roche Diabetes Care GmbH, filed in Opposition Proceeding Against EP 2 380 980, dated Jun. 4, 2018 (21 pages). |
| Response by Roche Diabetes Care GmbH, filed in Opposition Proceeding Against EP 2 380 980, dated Sep. 29, 2017 (10 pages). |
| Grounds of Appeal by Toyobo Co., Ltd., filed in Opposition Proceeding Against EP 2 380 980, dated Jan. 25, 2018 (45 pages). |
| Response by Toyobo Co., Ltd., filed in Opposition Proceeding Against EP 2 380 980, dated Nov. 29, 2017 (10 pages). |
| Office Action in EP Application No. 11 156 649.3, dated Apr. 12, 2013 (4 pages). |
| Office Action in EP Application No. 11 156 649.3, dated May 31, 2012 (4 pages). |
| Office Action in EP Application No. 11 156 649.3, dated Aug. 12, 2013 (4 pages). |
| Office Action in EP Application No. 11 156 649.3, dated Nov. 28, 2012 (4 pages). |
| Response to Office Action in EP Application No. 11 156 649.3, dated Feb. 11, 2013 (6 pages). |
| Response to Office Action in EP Application No. 11 156 649.3, dated Apr. 26, 2012 (9 pages). |
| Response to Office Action in EP Application No. 11 156 649.3, dated Jul. 30, 2013 (25 pages). |
| Response to Office Action in EP Application No. 11 156 649.3, dated Oct. 16, 2013 (9 pages). |
| Response to Office Action in EP Application No. 11 156 649.3, dated Oct. 31, 2012 (13 pages). |
| Pairwise Sequence Alignment, filed in Opposition Proceeding Against EP 2 380 980, dated May 23, 2017 (3 pages). |
| FAD-dependent Glucose Dehydrogenase [R. emersonii], GenBank No. BAV89805.1, filed in Opposition Proceeding Against EP 2 380 980, dated Jul. 7, 2017 (1 page). |
| Emboss Needle—Alignment, filed in Opposition Proceeding Against EP 2 380 980, dated Sep. 21, 2017 (1 of 2) (3 pages). |
| Emboss Needle—Alignment, filed in Opposition Proceeding Against EP 2 380 980, dated Sep. 21, 2017 (2 of 2) (3 pages). |
| SEQ ID Nos. 9 and 10, filed in Opposition Proceeding Against EP 2 380 980 (2 pages). |
| FASTA Query Results, filed in Opposition Proceeding Against Ep 2 380 980, dated Sep. 21, 2017 (1 page). |
| Christensen et al., “High Level Expression of Recombinant Genes in Aspergillus oryzae,” Nature Biotechnology, 6:1419-1422 (1988). |
| Hannig et al., “Strategies for optimizing heterologous protein expression in Escherichia coli,” TIBTECH, 16:54-60 (1998). |
| Heilmann et al., “Identification and isolation of glucose dehydrogenase genes of Bacillus megaterium M1286 and their expression in Escherichia coli,” Eur. J. Biochem., 174:485-490 (1988). |
| Markwell et al., “Aspergillus niger mutants with increased glucose oxidase production,” Appl. Microbial. Biotechnol., 30:166-169 (1989). |
| Office Action in U.S. Appl. No. 16/145,106, dated Jan. 3, 2019 (36 pages). |
| Office Action in U.S. Appl. No. 16/145,132, dated Jan. 2, 2019 (31 pages). |
| Office Action in U.S. Appl. No. 16/145,146, dated Jan. 3, 2019 (31 pages). |
| Office Action in U.S. Appl. No. 16/145,152, dated Jan. 2, 2019 (36 pages). |
| Office Action in U.S. Appl. No. 16/145,165, dated Jan. 2, 2019 (31 pages). |
| Office Action in U.S. Appl. No. 16/145,166, dated Jan. 2, 2019 (36 pages). |
| Office Action in U.S. Appl. No. 16/145,170, dated Jan. 2, 2019 (35 pages). |
| Office Action in U.S. Appl. No. 16/145,174, dated Jan. 2, 2019 (32 pages). |
| Office Action in U.S. Appl. No. 16/145,178, dated Jan. 2, 2019 (31 pages). |
| Office Action in U.S. Appl. No. 16/145,184, dated Jan. 7, 2019 (35 pages). |
| Office Action in U.S. Appl. No. 16/145,190, dated Jan. 2, 2019 (31 pages). |
| Office Action in U.S. Appl. No. 16/145,191, dated Jan. 3, 2019 (30 pages). |
| Record of Oral Hearing in U.S. Appl. No. 12/851,668, mailed Jun. 20, 2017 (15 pages). |
| Federal Circuit Opinion in U.S. Appl. No. 12/851,668, issued Jan. 29, 2019 (16 pages). |
| Petition for Post Grant Review in PGR2019-00031, U.S. Pat. No. 9,957,543, with Exhibits 1001 to 1019, filed Jan. 30, 2019 (840 pages). |
| Petition for Post Grant Review in PGR2019-00032, U.S. Pat. No. 9,976,125, with Exhibits 1001 to 1028, filed Jan. 30, 2019 (1454 pages). |
| Merry et al., “Chemical and Enzymatic Release of Glycans from Glycoproteins,” Methods in Molecular Biology, 213:27-40 (2003). |
| Definition of “Eluates” from the Free Dictionary, filed in Opposition Proceeding Against EP 2 380 980, dated Feb. 28, 2019 (1 page). |
| Declaration of Y. Nishiya, filed in Opposition Proceeding Against EP 2 380 980, dated Feb. 26, 2019 (2 pages). |
| Declaration of U. Kinkeldey, filed in Opposition Proceeding Against EP 2 380 980, dated Mar. 1, 2019 (11 pages). |
| Definition of “Encompass,” filed in Opposition Proceeding Against EP 2 380 980, undated (1 page). |
| Opposition by Toyobo Co., Ltd., filed in Opposition Proceeding Against EP 2 380 980, dated Mar. 5, 2019 (11 pages). |
| Letter by W. Hörschler, filed in Opposition Proceeding Against EP 2 380 980, dated Dec. 21, 2018 (1 page). |
| Office Action in Japanese Appl. No. 2017-242354, dated Dec. 11, 2019 (4 pages). |
| Office Action in U.S. Appl. No. 15/955,650, dated Feb. 8, 2019 (6 pages). |
| Alignment to U.S. Pat. No. 7,553,649; SEQ ID No. 4; Jul. 2012. |
| Alignment to U.S. Pat. No. 7,553,649; SEQ ID No. 5; Sep. 2012. |
| Amendment and Response to Office Action filed Apr. 1, 2019 in U.S. Appl. No. 16/145,170 (11 pages). |
| Amendment and Response to Office Action filed Apr. 1, 2019 in U.S. Appl. No. 16/145,174 (11 pages). |
| Amendment and Response to Office Action filed Mar. 7, 2019 in U.S. Appl. No. 16/145,178 (10 pages). |
| Amendment and Response to Office Action filed Mar. 20, 2019 in U.S. Appl. No. 16/145,184 (11 pages). |
| Amendment and Response to Office Action filed Mar. 7, 2019 in U.S. Appl. No. 16/145,190 (11 pages). |
| Amendment and Response to Office Action filed Mar. 20, 2019 in U.S. Appl. No. 16/145,191 (11 pages). |
| Decision to Grant Patent in Japanese Appl. No. JP 2017-242354, dated Apr. 2, 2019 (4 pages). |
| Patent Owner's Preliminary Response in Case No. PGR2019-00031, filed May 28, 2019 (74 pages). |
| Patent Owner's Preliminary Response in Case No. PGR2019-00032, filed May 28, 2019 (53 pages). |
| Office Action in U.S. Appl. No. 16/145,170, dated May 29, 2019 (18 pages). |
| Office Action in U.S. Appl. No. 16/145,178, dated May 30, 2019 (25 pages). |
| Office Action in U.S. Appl. No. 16/145,184, dated May 24, 2019 (19 pages). |
| Office Action in U.S. Appl. No. 16/145,190, dated May 23, 2019 (19 pages). |
| Office Action in U.S. Appl. No. 16/145,191, dated May 30, 2019 (26 pages). |
| Response to Office Action in U.S. Appl. No. 16/145,170, filed Jun. 11, 2019 (7 pages). |
| Response to Office Action in U.S. Appl. No. 16/145,178, filed Jun. 11, 2019 (6 pages). |
| Response to Office Action in U.S. Appl. No. 16/145,184, filed Jun. 11, 2019 (6 pages). |
| Response to Office Action in U.S. Appl. No. 16/145,190, filed Jun. 11, 2019 (6 pages). |
| Response to Office Action in U.S. Appl. No. 16/145,191, filed Jun. 11, 2019 (6 pages). |
| Office Action in U.S. Appl. No. 15/927,949, dated Apr. 19, 2019 (6 pages). |
| Office Action in U.S. Appl. No. 15/927,976, dated May 20, 2019 (6 pages). |
| Office Action in U.S. Appl. No. 15/928,012, dated May 17, 2019 (6 pages). |
| Office Action in U.S. Appl. No. 15/928,027, dated Apr. 22, 2019 (6 pages). |
| Amendment and Response to Office Action in U.S. Appl. No. 15/927,949, filed Jun. 19, 2019 (7 pages). |
| Amendment and Response to Office Action in U.S. Appl. No. 15/927,976, filed Jun. 19, 2019 (7 pages). |
| Amendment and Response to Office Action in U.S. Appl. No. 15/928,027, filed Jun. 19, 2019 (7 pages). |
| Office Action in U.S. Appl. No. 16/278,030, dated Apr. 18, 2019 (21 pages). |
| Office Action in U.S. Appl. No. 16/278,008, dated May 2, 2019 (25 pages). |
| Office Action in U.S. Appl. No. 16/278,019, dated Apr. 18, 2019 (20 pages). |
| Office Action in U.S. Appl. No. 16/278,025, dated May 2, 2019 (25 pages). |
| Amendment and Response to Office Action in U.S. Appl. No. 16/278,030, filed May 23, 2019 (9 pages). |
| Amendment and Response to Office Action in U.S. Appl. No. 16/278,008, filed May 23, 2019 (9 pages). |
| Amendment and Response to Office Action in U.S. Appl. No. 16/278,019, filed May 23, 2019 (9 pages). |
| Amendment and Response to Office Action in U.S. Appl. No. 16/278,025, filed May 23, 2019 (9 pages). |
| Applicant-Initiated Interview Summary in U.S. Appl. No. 16/145,178, dated May 2, 2019 (3 pages). |
| Applicant-Initiated Interview Summary in U.S. Appl. No. 16/145,184, dated May 7, 2019 (4 pages). |
| Applicant-Initiated Interview Summary in U.S. Appl. No. 16/145,190, dated May 7, 2019 (4 pages). |
| Applicant-Initiated Interview Summary in U.S. Appl. No. 16/145,191, dated May 2, 2019 (3 pages). |
| Applicants' Summary of Apr. 24, 2019 Interview in U.S. Appl. No. 16/145,178, filed Apr. 29, 2019 (9 pages). |
| Applicants' Summary of Apr. 24, 2019 Interview in U.S. Appl. No. 16/145,184, filed Apr. 29, 2019 (9 pages). |
| Applicants' Summary of Apr. 24, 2019 Interview in U.S. Appl. No. 16/145,190, filed Apr. 29, 2019 (9 pages). |
| Applicants' Summary of Apr. 24, 2019 Interview in U.S. Appl. No. 16/145,191, filed Apr. 29, 2019 (9 pages). |
| Non-Final Office Action from U.S. Appl. No. 15/955,650 dated Oct. 29, 2019. |
| Non-Final Office Action from U.S. Appl. No. 16/145,174 dated Oct. 31, 2019. |
| Tsuboi et al., “Improvement of the Aspergillus oryzae Enolase Promoter (P-enoA) by the Introduction of cis-Element Repeats,” Biosci. Biotechnol. Biochem., vol. 69, No. 1, 2005, pp. 206-208. |
| Advisory Action dated Jun. 26, 2019 in U.S. Appl. No. 16/145,170 (9 pages). |
| Advisory Action dated Jun. 27, 2019 in U.S. Appl. No. 16/145,178 (11 pages). |
| Advisory Action dated Jun. 27, 2019 in U.S. Appl. No. 16/145,184 (9 pages). |
| Advisory Action dated Jun. 27, 2019 in U.S. Appl. No. 16/145,191 (12 pages). |
| Advisory Action dated Jun. 28, 2019 in U.S. Appl. No. 16/145,190 (10 pages). |
| Advisory Action from U.S. Appl. No. 16/145,170 dated Jun. 26, 2019. |
| Advisory Action from U.S. Appl. No. 16/145,174 dated Sep. 18, 2019. |
| Advisory Action from U.S. Appl. No. 16/145,178 dated Jun. 27, 2019. |
| Advisory Action from U.S. Appl. No. 16/145,184 dated Jun. 27, 2019. |
| Advisory Action from U.S. Appl. No. 16/145,190 dated Jun. 28, 2019. |
| Advisory Action from U.S. Appl. No. 16/145,191 dated Jun. 27, 2019. |
| Final Office Action from U.S. Appl. No. 16/278,019 dated Aug. 16, 2019. |
| Final Office Action from U.S. Appl. No. 16/278,025 dated Aug. 22, 2019. |
| Final Office Action from U.S. Appl. No. 16/278,030 dated Aug. 16, 2019. |
| Non-Final Office Action from U.S. Appl. No. 15/927,949 dated Sep. 20, 2019. |
| Non-Final Office Action from U.S. Appl. No. 15/927,976 dated Sep. 20, 2019. |
| Non-Final Office Action from U.S. Appl. No. 15/928,027 dated Sep. 20, 2019. |
| Restriction Requirement from U.S. Appl. No. 16/145,168 dated Oct. 11, 2019. |
| Restriction Requirement from U.S. Appl. No. 16/145,196 dated Oct. 11, 2019. |
| Decision Denying Institution of Post Grant Review of U.S. Pat. No. 9,957,543 B2 dated Aug. 15, 2019, 26 pages. |
| Decision Granting Institution of Post Grant Review of U.S. Pat. No. 9,976,125 B2 dated Aug. 15, 2019, 43 pages. |
| Chen et al., “Mechanisms by Which Wheat Bran and Oat Bran Increase Stool Weight in Humans,” The American of Journal Clinical Nutrition, vol. 68, No. 3, pp. 711-719, 1998. |
| Response to Oct. 31, 2019 Office Action filed on Dec. 24, 2019 from U.S. Appl. No. 16/145,174. |
| Second Declaration of Katsuya Gomi Under 37 CFR 1.132 dated Dec. 20, 2019 from U.S Appl. No. 16/145,174. |
| Yan et al., “Purification and Characterization of a Glucose-Tolerant β-Glucosidase from Aspergillus niger CCRC 31494,” Biosci. Biotechnol. and Biochem., vol. 61, No. 6, pp. 965-970, 1997. |
| Takara Bio USA, Inc. at https://www.takarabio.com/products/protein-research/glycobiology/glycopeptidase-f attached: “Glycopeptidase F (Peptide: N-glycosidase F),” downloaded Dec. 23, 2019. |
| Millipore Sigma at https://www.emdmillipore.com/US/en/product/N-Glycosidase-F-Chryseobacterium-meningosepticum-Recombinant-E.-coli,EMD_BIO-362300, downloaded Apr. 19, 2019. |
| Fujita et al., “Production of Two Types of Phytase from Aspergillus oryzae During Industrial Koji Making,” J. Biosci. Bioeng., vol. 95, No. 5, pp. 460-465, 2003. |
| Chen et al., “Mechanisms by Which Wheat Bran and Oat Bran Increase Stool Weight in Humans,” The American Journal of Clinical Nutrition, vol. 68, No. 3, pp. 711-719, 1998. |
| Wang et al., “Survey of the Transcriptome of Aspergillus oryzae via Massively Parallel mRNA Sequencing,” Nucleic Acids Research, vol. 38, No. 15, pp. 5075-5087, 2010. |
| Counterstatement filed in European Patent Office on Dec. 6, 2019 relating to Opposition of European Patent No. 2,380,980. |
| Figure 3 of Hata (2002), (D36b), J. Agricult. Chem. P. 19-22, “Promoter Analysis with GUS Reporter Gene.”. |
| Definition of “encompass” at internet address: https://www.merriam-webster.com/dictionary/encompass and synonyms and antonyms for “include” at internet address: https://www.merriam-webster.com/dictionary/include#synonyms, (D126) Merriam-Webster Dictionary, as submitted on Dec. 6, 2019 in Opposition of European Patent No. 2,380,980. |
| Lottspeich et al., “Chromatographische Trennmethoden,” (D127), Bioanalytik, Spektrum Akademischer Verlag GmbH, Heidelberg, Berlin, Germany, 1998, Chapter 9, pp. 195-198. |
| Ausubel et al., “Current Protocols in Molecular Biology—Preparing DNA Using DEAE-Cellulose Column Chromatography,” (D128), Supplement 10, John Wiley & Sons Inc., Ringbou edition, Dec. 4, 2003. |
| Decision of Technical Board of Appeal 3.3.07 of Feb. 27, 2018, (T0156-3.3.07), Case No. T 0156/15. |
| Communication Prior to First Office Action filed on Nov. 18, 2019 from U.S. Appl. No. 16/278,030. |
| Non-Final Office Action from U.S. Appl. No. 16/278,030 dated Dec. 26, 2019. |
| Non-Final Office Action from U.S. Appl. No. 15/928,012 dated Jan. 28, 2020. |
| Yoshida et al., “Secretion of Water Soluble Pyrroloquinoline Quinone Glucose Dehydrogenase by Recombinant Pichia pastoris,” Enzyme and Microbial Technology, vol. 30, 2002, pp. 312-318. |
| Examiner's Answer dated Feb. 7, 2020 in response to the Appeal Brief filed on Oct. 22, 2019, in U.S. Appl. No. 16/145,178. |
| Applicant-Initiated Interview Summary dated Jan. 30, 2020 in U.S. Appl. No. 16/278,030. |
| Applicants' Summary of Jan. 22, 2020 Applicant-Initiated Interview filed on Feb. 11, 2020 from U.S. Appl. No. 16/278,030. |
| Non-Final Office Action from U.S. Appl. No. 16/145,168 dated Feb. 13, 2020. |
| Petitioner's Opposition to Patent Owner's Motion to Amend Under 37 C.F.R. § 42.221 dated Feb. 14, 2020, Case No. PGR2019-00032, 32 pages. |
| Dec. 1, 2008 translation of non-English U.S. Appl. No. 60/788,252. |
| Katrlik et al., “Whole Cell Amperometric Biosensor Based on Aspergillus niger for Determination of Glucose With Enhanced Upper Linearity Limit,” Analytica Chimica Acta, vol. 331, 1996, pp. 225-232. |
| Notice of Allowance from U.S. Appl. No. 16/145,174 dated Mar. 2, 2020. |
| Notice of Allowance from U.S. Appl. No. 15/927,949 dated Mar. 10, 2020. |
| Preliminary Guidance, Patent Owner's Motion to Amend dated Mar. 10, 2020, Case No. PGR2019-00032, 11 pages. |
| Petitioner's Opposition to Revised Motion to Amend Under 37 C.F.R. § 42.221 dated Apr. 30, 2020, Case No. PGR2019-00032, including 13 exhibits, 190 pages. |
| Non-Final Office Action from U.S. Appl. No. 16/145,196 dated Jun. 25, 2020. |
| Notice of Allowance from U.S. Appl. No. 15/928,027 dated Jun. 29, 2020. |
| Final Office Action from U.S. Appl. No. 16/278,030 dated Jul. 8, 2020. |
| Decision on Petition from U.S. Appl. No. 16/145,178 dated Jul. 9, 2020. |
| Examiner's Answer from U.S. Appl. No. 16/145,184 dated Jul. 13, 2020. |
| Examiner's Answer from U.S. Appl. No. 16/145,170 dated Jul. 13, 2020. |
| Patent Owners' Reply to Petitioner's Opposition to Patent Owners' Revised Motion to Amend Under 37 C.F.R. § 42.221 dated May 21, 2020, Case No. PGR2019-00032, including 4 exhibits, 41 pages. |
| Petitioner's Surreply to Patent Owners' Reply to Opposition to Revised Motion to Amend Under 37 C.F.R. § 42.221 dated Jun. 11, 2020, Case No. PGR2019-00032, 20 pages. |
| Record of Oral Hearing dated Jul. 16, 2020, Case No. PGR2019-00032, 40 pages. |
| Decision to Grant a Patent dated Aug. 4, 2020 from Japanese Patent Application No. 2019-100865, with English language machine translation. |
| Decision—Final Written Decision Granting-in-Part and Denying-in-Part Patent Owners' Motion to Amend 35 U.S.C. § 328 dated Aug. 12, 2020, Case No. PGR2019-00032, 34 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20190177698 A1 | Jun 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 10540025 | US | |
| Child | 12396724 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 12851668 | Aug 2010 | US |
| Child | 16278008 | US | |
| Parent | 12396724 | Mar 2009 | US |
| Child | 12851668 | US |
